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ABSTRACT 
 
 Vascular smooth muscle cells regulate blood flow by contracting and relaxing 
blood vessels. Vascular smooth muscle cells display one of two distinct phenotypes: 
contractile or synthetic. The contractile phenotype enables cells to contract, and the 
majority of cells in healthy blood vessels exhibit this phenotype. Transition to the 
synthetic phenotype is associated with abnormal mechanical forces and the development 
of vascular diseases, including hypertension and atherosclerosis. Cell-extracellular matrix 
interactions and mechanical stimulation are factors that affect phenotypic modulation.  
 Micropatterning techniques create a microenvironment used to control cell 
morphology, adhesion, migration, proliferation, and differentiation. Vascular smooth 
muscle cells are circumferentially arranged in blood vessels, so parallel cell alignment 
mimics the native environment. Micropatterning vascular smooth muscle cells, either 
onto topographical features or extracellular matrix protein patterns, has been shown to 
promote a more contractile, in vivo-like phenotype. Vascular smooth muscle cells are 
exposed to continuous mechanical signaling from pulsatile blood flow, which enforces 
the contractile phenotype. Applying a physiologically relevant, cyclic stretching regimen 
to vascular smooth muscle cells also promotes contractile functioning. The purpose of 
this study was to determine the effects of micropatterning and mechanical stimulation on 
vascular smooth muscle cell phenotype.  
 Three micropatterning techniques were implemented to determine the best 
method for aligning vascular smooth muscle cells. Microstamping was effective at 
patterning collagen but did not promote sufficient cell alignment. Stencil patterning 
  iii 
vascular smooth muscle cells on a collagen layer was found to promote cell alignment 
with minimal cell spreading. Stenciled cells were exposed to physiological cyclic stretch 
using the MechanoCulture FX mechanical stimulation system (CellScale). The 
combination of stencil patterning and stretching reduced cell proliferation and promoted a 
more contractile phenotype. 
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CHAPTER ONE 
 
INTRODUCTION  
 
1.1 MOTIVATION  
 Vascular smooth muscle cells regulate blood flow by contracting and relaxing 
blood vessels. Biomechanical signals received from both the topography of the 
surrounding extracellular matrix, as well as the mechanical forces from blood flow, 
maintain homeostasis of vascular smooth muscle cells. Micropatterning dictates cellular 
morphology and functions, with parallel lines promoting a contractile phenotype in 
vascular smooth muscle cells. Micropatterning techniques, including microstamping, 
microfluidic patterning, and stencil patterning were implemented to create a 
microenvironment representative of in vivo vascular conditions
1
. The goal of 
micropatterning was to align vascular smooth muscle cells in a way that mimics their 
circumferential arrangement and contractile functioning in blood vessels.  
 Cell stretching devices are used to replicate the mechanical forces received by 
vascular smooth muscle cells. Cell stretching at a physiologically relevant regimen has 
been shown to promote a contractile phenotype in vascular smooth muscle cells
2
. The 
combination of mircopatterning and stretching is used to promote a more in vivo-like 
phenotype with associated contractile functions. Manipulating the cellular 
microenvironment allows for control over cellular phenotype and behaviors. The ability 
to produce vascular smooth muscle cells with a desired phenotype is necessary to create 
experimental models of both healthy and diseases states. One third of the world’s 
  2 
population suffers from vascular disease, so the ability to more effectively and accurately 
study pathogenesis and potential therapeutics is essential
3
. The goal of this study is to 
investigate phenotypic changes associated with stretching of micropatterned vascular 
smooth muscle cells.  
 
1.2 RESEARCH AIMS 
Aim 1: Optimize micropatterning techniques to align vascular smooth muscle cells.  
 The first aim of this research project was to optimize a micropatterning technique 
to create parallel lines of vascular smooth muscle cells. Parallel cell alignment mimics the 
natural circumferential arrangement of vascular smooth muscle cells in blood vessels, 
encouraging more in vivo-like cell behaviors
1
. The extracellular matrix and topographical 
features of a cell’s microenvironment provide biophysical and biochemical cues 
important in the regulation of cell responses. Therefore, implementing a method to align 
vascular smooth muscle cells promotes contractile phenotypes.  
 
Aim 2: Analyze phenotype changes by staining micropatterned, stretched cells for actin 
cytoskeleton and collagen.  
 Vascular smooth muscle cells were stretched with a regimen physiologically 
equivalent to the mechanical forces of pulsatile blood flow present in a healthy blood 
vessel. The majority of healthy vascular smooth muscle cells exhibit a contractile 
phenotype, so cyclic strain mechanical stimulation was implemented to produce a more 
natural, contractile phenotype
2
. To analyze the effects of stretching micropatterned 
  3 
vascular smooth muscle cells, immunocytochemistry staining for contractile elements and 
collagen was performed. Phalloidin stained actin filaments, a part of the cell’s 
cytoskeleton, allowing for visualization of the phenotype of the cell. Contractile vascular 
smooth muscle cells secrete minimal extracellular matrix proteins compared to synthetic 
cells, so quantification of collagen can also reveal cellular behaviors
4
. 
 
Aim 3: Quantify proliferation rates, an indicator of vascular smooth muscle phenotype, 
by performing a proliferation assay on micropatterned, stretched cells.  
 Contractile vascular smooth muscle cells have lower proliferation rates compared 
to synthetic cells, so a proliferation assay was performed to quantify proliferation. 
Determining proliferation rates is a way to assess the amount of contractile functioning of 
vascular smooth muscle cells.   
 
1.3 REFERENCES  
1. Y. Li, et al. “Engineering cell alignment in vitro.” Biotechnology Advances, 32: 347-
365, 2014.  
2. G. Ye, et al. “The role of mechanotransduction on vascular smooth muscle myocytes 
cytoskeleton and contractile function.” The Anatomical Record, 297(9): 1758-
1769, 2014.  
3. T.S. Al-Shehabi, et al. “Anti-atherosclerotic plants which modulate the phenotype of 
vascular smooth muscle cells.” Phytomedicine, 23: 1068-1081, 2016.  
4. S.S.M. Rensen, et al. “Regulation and characteristics of vascular smooth muscle cell 
phenotypic diversity.” Netherlands Heart Journal, 15(3): 100-108, 2007.  
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CHAPTER TWO 
BLOOD VESSELS AND VASCULAR SMOOTH MUSCLE CELLS  
2.1 BLOOD VESSELS  
2.1.1 Overview of Vascular Anatomy  
 The cardiovascular system is made up of the heart, blood vessels, and blood. It is 
a closed circuit system with the purpose of circulating blood throughout blood vessels to 
all tissues of the body. This facilitates nutrient and gas exchange while providing a 
transportation system for cells of the immune system
1
. An essential function of the 
vascular system is to maintain cellular homeostasis throughout the body by promoting 
nutrient absorption and cellular waste removal through the circulation of blood
2
. Blood 
vessels are divided into five categories based on lumen diameter and the direction of 
blood flow: arteries, arterioles, capillaries, venules, and veins (Figure 2.1)
3
.  Arteries 
carry oxygenated blood away from the heart, and a thick muscular layer enables them to 
withstand high pressures as blood is ejected from the heart. Large arteries, including the 
aorta, are classified as elastic arteries because they contain many layers of elastin to allow 
for blood vessel expansion and restriction in response to volume changes
3
. Small arteries 
and arterioles are progressively smaller in diameter, and they are considered muscular 
arteries due to their function in rapid distribution of blood throughout the body
2
. 
Capillaries are tiny, branching vessels that facilitate direct gas and nutrient exchange with 
cells
3
. Deoxygenated blood flows from capillaries into venules, which transition into 
larger veins to transport blood back to the heart.  
  5 
 
          Figure 2.1: Blood Vessel Classification and Direction of Blood Flow4 
2.1.2 Blood Vessel Structure  
 Blood vessels vary in structure depending on anatomical location and 
physiological requirements. Generally, blood vessels are composed of several cell and 
connective tissue types organized in three layers: the tunica adventitia, tunica media, and 
tunica intima (Figure 2.2)
5
. The tunica adventitia, or tunica externa, is the outermost 
layer, and it is made up of extracellular matrix (ECM) proteins that allow it to serve as 
the structural support of the blood vessel
5,6
. Within the adventitia, fibroblasts and 
progenitor cells are present. Fibroblasts maintain the ECM scaffolding network, while 
stem and vascular progenitor cells differentiate into many vascular cell types based on 
biochemical and mechanical signaling
5
. The tunica media is the muscular middle layer of 
the blood vessel, and it contains circumferentially arranged vascular smooth muscle cells 
along with a network of elastin and collagen fibers
5
. The main function of the tunica 
media is to regulate blood flow by adjusting the blood vessel diameter through the 
processes of vasoconstriction, or contraction, and vasodilation, or relaxation
3,6
. The 
tunica media is the thickest layer of an arterial wall. Up to 75% of the tunica media can 
contain vascular smooth muscle cells, and due to the presence of high amounts of 
collagen and elastin fibers, arteries are able to withstand the mechanical forces associated 
with pulsatile blood flow
7,8
. The tunica intima is the innermost layer, and it is composed 
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of a single layer of endothelial cells, along with a basement membrane (sub-endothelial 
layer) and inner elastic lamina
3,5
. Endothelial cells line the lumen of blood vessels and 
have direct contact with blood, controlling the diffusion of nutrients and wastes to 
maintain cellular homeostasis
2,9
. The cellular and connective tissue composition dictates 
the physiological function of each tunic, as well as the blood vessel as a whole.  
 
Figure 2.2: Blood Vessel Tunics in an Artery, Vein, and Capillary
10
  
2.1.3 Mechanical Forces Affecting Blood Vessels  
 The vascular system is a complex, branching network of vessels influenced by a 
combination of mechanical forces
11
. Hemodynamics is the study of the fluid dynamics of 
blood flow throughout this complex system based on physical factors including blood 
pressure, cardiac output, and the resistance of a vessel to flow
12,13,14
. Blood pressure is 
defined as the force that blood applies to the inside of blood vessel walls, and it accounts 
for a large portion of the mechanical forces exerted on blood vessles
7,15,16
. Arterial blood 
flow is pulsatile due to the constant ejection of blood from the heart, so blood pressure is 
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much higher in arteries than veins
17
. Large arteries, such as the aorta, have 
circumferentially arranged layers, enabling them to dampen pulsatile blood flow from the 
heart into a steady, uniform flow as blood enters smaller vessels
7,17
. The elastic nature of 
blood vessel walls serves to reduce the blood pressure exerted on subsequent vessels, 
which is an example of hemodynamic homeostasis
11
. There are three patterns of blood 
flow that are recognized in blood vessels: laminar, turbulent, and bolus flow (Figure 
2.3)
12
. Laminar blood flow is found in the majority of vessels in a healthy vascular 
system, and it occurs under steady flow conditions as blood moves in parallel layers 
down a blood vessel
18,19
. Turbulent flow is characterized by the movement of random and 
chaotic layers, which occurs in either large arterial vessels or diseased vessels
12
. Bolus 
flow occurs in capillaries, where blood cells are required to assemble into a single-file 
line in order to travel through the vessel
12
.   
  
Figure 2.3: Types of Fluid Flow in Blood Vessels
12
  
 On the macroscopic level, blood vessels are subjected to many mechanical forces: 
pulsatile blood flow, shear stress, cyclic strain, and hydrostatic pressure (Figure 2.4)
20
. 
Shear stress can be defined as the frictional force generated by blood flow acting parallel 
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to the blood vessel wall
14,19
. The endothelial lining is in direct contact with blood, and the 
mechanical force associated with the shear stress of blood flow is necessary for 
endothelial cell homeostasis
19
. Cyclic strain is due to circumferential stretch that occurs 
when pulsatile blood flow is present in the vascular system
14
. Hydrostatic pressure is a 
normal stress that acts perpendicularly to the blood vessel wall
19
. Changes in these 
mechanical forces due to anatomical changes in the vascular system play an important 
role in the development of vascular diseases
17
. The combination of these naturally 
occurring mechanical forces maintain and regulate vascular and cellular homeostasis
16
.   
 
Figure 2.4: Mechanical Forces Present in Blood Vessels, A. Tensile stress (cyclic strain) from 
circumferential stretch, B. Normal stress from hydrostatic pressure, and C. Shear stress from 
unidirectional blood flow
19
  
 
2.2 VASCULAR SMOOTH MUSCLE CELLS  
2.2.1 Characteristics of Smooth Muscle  
 There are three types of muscle tissue: skeletal, cardiac, and smooth (Figure 2.5). 
Skeletal muscle cells, or fibers, are multinucleated and contain sarcomeres, visible as an 
alternating, striated pattern of thick and thin microfilaments which are responsible for 
muscle contraction. Skeletal muscles include axial and appendicular muscles, and 
contraction is voluntary due to innervation by the somatic nervous system
7
. The muscular 
A.  
B.  
C.  
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wall of the heart is composed of individual cardiac muscle cells, which are striated in 
appearance and connect to surrounding muscle cells with intercalated discs. Cardiac 
muscle is stimulated by the autonomic nervous system, so contraction is involuntary
7
. 
Smooth muscle tissue is found in visceral organs, including the stomach and intestines, as 
well as in hollow passageways, such as blood vessels. Smooth muscle is important in the 
movement of materials throughout the body; propelling blood through blood vessels is 
one example. Smooth muscle cells have a single, central nucleus and are described as 
fusiform, elongated, and spindle-shaped, with a wider middle and narrowed ends
7
. Cells 
are relatively small, with lengths ranging from 50 to 200 μm and diameters of 5 to 10 
μm7. Smooth muscle differs from skeletal and cardiac muscle in that it is not striated; 
while thick and thin filaments are present in smooth muscle, they are not organized as a 
sarcomere. Additionally, smooth muscle contraction is involuntary, has a slow 
contraction speed, and is resistant to fatigue due to lower ATP requirements compared to 
skeletal muscle.  
 
Figure 2.5: Representative cells of muscle tissue types, A. Bundle of multinucleated skeletal muscle 
fibers, B. Fusiform smooth muscle cells with central nuclei, and C. Cardiac muscle cells
21
 
 
 
 
A. 
B. 
C. 
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2.2.2 Structural Characteristics of Vascular Smooth Muscle Cells  
 Vascular smooth muscle cells (VSMCs) are the most abundant type of cell found 
in blood vessels
22
. Similar to other types of smooth muscle cells, they are spindle-shaped 
and have a central nucleus. Additionally, vascular smooth muscle cells are aligned next to 
each other in a staggered, parallel fashion. VSMCs are usually arranged circumferentially 
in blood vessels, with their alignment dependent upon shear stress in the location of the 
vessel
23
. In vitro, the phenotype displayed by vascular smooth muscle cells depends on 
the artery of origin, as well as duration of time in culture
24,25
 (Figures 2.6-2.7). The main 
physical elements of the cell include: the basal lamina, mitochondria, caveolae, 
sarcoplasmic reticulum, cytoskeleton, and the contractile apparatus (Figure 2.8)
5
.  
 
Figure 2.6: Primary porcine VSMCs (100X), A. Aortic SMCs (2 days), B. Aortic SMCs (10 days), C. 
Iliac Artery SMCs (2 days), D. Iliac Artery SMCs (10 days) [modified from ref. 23]  
 
 
A. B. 
C. D. 
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Figure 2.7: Primary human umbilical artery smooth muscle cells, A. 10 days, B. 17 days, (100X) 
[modified from ref. 24] 
 Vascular smooth muscle cells produce their own reticular network of ECM 
protein fibers, including elastin and collagen types I and III
26
. These ECM proteins form 
an outer layer, termed the basal lamina, that surrounds the sarcolemma, or cell 
membrane, of individual smooth muscle cells. The basal lamina provides unity and 
attachment among neighboring cells
26
.  As such, vascular smooth muscle cells are 
attached to neighboring cells by either indirect ECM assemblies or direct cell-cell 
contacts through desmosomes. The mitochondrion is a mighty organelle responsible for 
generating the ATP necessary for cellular functions
5
. Some studies show that 
mitochondria in vascular smooth muscle cells might also play a role in cell signaling
26
. 
Caveolae are indentations in the sarcolemma, vital in cell signaling pathways as well as 
vascular contraction. The sarcoplasmic reticulum (SR) is an organelle made of intricate 
tubules, noted for its role in calcium storage, release, and uptake
5
. The function of the 
sarcoplasmic reticulum depends on its location: the peripheral SR maintains calcium 
homeostasis through calcium release, while the central SR supplies calcium to initiate 
smooth muscle contraction
5
. 
A. B. 
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Figure 2.8: Cytoskeletal Arrangement of Vascular Smooth Muscle Cells [modified from ref. 25] 
 The arrangement of structural components throughout vascular smooth muscle 
cells forms two main entities: the scaffolding cytoskeleton and the contractile apparatus
26
.  
The cytoskeleton does not simply provide shape and structure to the cell, but it is also 
important in protecting organelles and promoting cellular activities. Cytoskeletal proteins 
must constantly reorganize and adapt to cellular activities as well as changing external 
conditions. The cytoskeleton of the cell is composed of three fibers: microtubules, 
intermediate filaments, and microfilaments
5
. Microtubules are the largest, made from 
alpha and beta tubulin polymers, and they are important in not only maintaining cell 
shape but also intracellular transport
5,27
.  The main role of the intermediate filament 
network is to provide structural support and organization for the cell
26
. Desmin and 
vimentin are proteins that form intermediate filament bundles, and larger arteries express 
a higher vimentin/desmin ratio than smaller arteries
27
. Intermediate filament bundles run 
longitudinally or diagonally through the cell, and they are connected by either 
cytoplasmic dense bodies or submembranous dense plaque structures
26
.  Dense bodies are 
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distributed throughout the cytoplasm, and they serve as an attachment or anchoring site, 
connecting the intermediate filament network
28
.  Dense plaques are found below the 
sarcolemma, and they anchor intermediate filaments to the extracellular matrix 
surrounding the cell. Cell-cell contacts occur between dense plaques from adjacent cells, 
forming a desmosome structure
26
.  
 Microfilaments are the thinnest fibers, and they include thick filaments (myosin) 
and thin filaments (actin)
28
. Smooth muscle myosin is composed of two heavy and two 
light chains, and it is involved in regulating smooth muscle contraction
27
.  Several 
isoforms, or protein variants, of actin are located in smooth muscle: α- smooth muscle 
actin, γ-smooth muscle actin, β-non-muscle actin, and γ-non-muscle actin (Figure 2.9)27. 
Smooth muscle actin is associated with myosin for contractile functions, and large 
arteries contain about 60% α- smooth muscle actin27. Together, actin and myosin form 
the contractile apparatus, or contractile unit, of the cell, forming a network by inserting 
into dense bodies and dense plaques along with the intermediate filaments.  In this way, 
dense bodies and plaques are analogous to Z-lines in the sarcomere of a skeletal muscle 
fiber
28
.  Therefore, some cytoskeletal components serve as structural support for 
maintaining cell shape, while the microfilaments function as the contractile apparatus of 
the cell.  
  14 
 
Figure 2.9: Microfilament Structure of a Vascular Smooth Muscle Cell
27
 
 
2.2.3 Functions of Vascular Smooth Muscle Cells  
 Maintaining vascular homeostasis is the main function of vascular smooth muscle 
cells, and this is achieved by the contraction and relaxation of blood vessels. Altering the 
diameter of the blood vessel lumen enables vascular smooth muscle cells to regulate 
blood pressure, blood flow/ distribution, and blood vessel tone
22,29
.   
 The contractile apparatus system is responsible for generating the tension to 
contract smooth muscle
5
. Smooth muscle contraction is stimulated by both biochemical 
and mechanical signals, including stretch from the cell itself
30
. Calcium ions serve as the 
initiator of smooth muscle contraction. After a stimulus occurs, the sarcoplasmic 
reticulum releases stored calcium into the cytoplasm, and simultaneously calcium ions 
enter the cell through calcium channels in the sarcolemma
30
. Together, these mechanisms 
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increase the concentration of cytosolic calcium. Next, calcium ions interact with the 
regulatory protein calmodulin, which causes the myosin light chain to be phosphorylated 
by the enzyme myosin kinase
31
. Phosphorylation of myosin allows myosin heads to 
interact with the actin of thin filaments (Figure 2.10).  
 
Figure 2.10: Organization of thick and thin filaments during relaxation and contraction [modified 
from ref. 5] 
 
 Since thin filaments are anchored to dense bodies in both the cytoplasm and on 
the sarcolemma, the movement of the thin and thick filaments sliding past each other 
pulls on the entire cytoskeletal network of the cell, including the intermediate filaments 
also attached to the same dense bodies
30
. This process causes the entire cell to contract, as 
seen in Figure 2.11. Calcium sensitization occurs to prolong the contractile force 
produced by the cell, and this process is regulated by the RhoA/ Rho kinase pathway
30
. 
Finally, smooth muscle relaxation occurs as excess calcium ions are removed through 
several mechanisms, including calcium uptake by the sarcoplasmic reticulum and 
calcium transport to extracellular fluid by sodium-calcium exchanger channels in the cell 
membrane
30
.  
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Figure 2.11: Smooth muscle cell contraction, A. Relaxed muscle cell, B. Contracted muscle cell
31
 
 
2.2.4 Vascular Smooth Muscle Cell Phenotypes  
 While the previous section describes the general structural characteristics and 
contractile functioning of vascular smooth muscle cells, it is important to note that there 
is phenotypic diversity among vascular smooth muscle cells. While phenotypes range 
across a spectrum, two characteristic phenotypes can be identified: contractile and 
synthetic
29
. These two phenotypes are associated with specific morphologies along with 
differing cellular functions. Vascular smooth muscle cells are highly differentiated, but 
not terminally differentiated: they are capable of transitioning reversibly between 
phenotypes
32
. The process of vascular smooth muscle cells switching between 
phenotypes is termed “phenotypic modulation”29. This plasticity allows vascular smooth 
muscle cells to adapt to the conditions of their local environment. Contractile VSMCs 
function to contract, while synthetic VSMCs are less contractile and have higher 
proliferation rates. Cell-cell and cell-extracellular matrix interactions, mechanical stimuli, 
and chemical cues are all factors that affect VSMC phenotype
33
. Figure 2.12 shows the 
physical appearance of the two phenotypes, as well as the cues that can promote each 
phenotype
33
.  
A. B. 
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Figure 2.12: Contractile and synthetic phenotypes of vascular smooth muscle cells [modified from 
ref. 32]  
 
 Contractile, or differentiated, VSMCs make up the majority of smooth muscle 
cells located in healthy adult blood vessels, contracting in order to regulate blood flow 
and pressure
29,32
. Contractile VSMCs have limited proliferation and migration, and they 
are described as quiescent yet active
34
. They secrete only small amounts of extracellular 
matrix proteins
29
. Contractile VSMCs adhere to the spindle-shaped morphology and have 
an abundance of contractile filaments to support their main function of contraction and 
relaxation
29
. The contractile phenotype can be confirmed through staining for various cell 
marker proteins: α- smooth muscle actin, SM22α, SM-calponin, smoothelin, and N-
cadherin
29
. The first four markers listed are associated with actin or the cytoskeleton, 
enabling visualization of the contractile elements specific to smooth muscle cells. N-
cadherin is a cell-cell adhesion molecule important in cell signaling among vascular 
smooth muscle cells
35
.  
 To note, it has been found that in vivo phenotypes can be maintained in vitro 
despite the differing environmental conditions
34
. Desired phenotypes can be purposefully 
manipulated using a variety of methods, including the addition of serum or growth 
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factors, choice of cell culture substrate, or the application of mechanical signals
34,36
. In 
fact, it has been shown that mechanical strain induces the contractile phenotype in 
vascular smooth muscle cells
29
.  Additionally, studies have shown that endothelial cells 
play a role in regulating and maintaining the contractile phenotype of surrounding 
vascular smooth muscle cells
32
.  The contractile phenotype is more likely to be expressed 
in vitro when cells are seeded at a higher density and there are increased cell-cell 
contacts, as well as when cells are plated in a more in-vivo like arrangement
22
. Also, 
studies have shown that both substrate stiffness and the properties of the extracellular 
matrix environment affects the phenotype of vascular smooth muscle cells
22,37
.  
 Vascular smooth muscle cells in the synthetic phenotype are termed 
dedifferentiated, and they exhibit a triangular or rhomboid shape
29,32
. The number of 
protein synthesis organelles increase in the synthetic phenotype, allowing the cells to 
produce more extracellular matrix proteins, including elastin and collagen. Synthetic 
VSMCs are also characterized by increased proliferation and migratory rates and 
decreased contractility
29
. There are not many protein markers specific to the synthetic 
phenotype, so traditionally staining for contractile markers along with proliferation and 
migration data is used to confirm phenotype
32
. Synthetic VSMCs are typically associated 
with vascular disease and injury
22
. Table 2.1 summarizes the common characteristics of 
the two phenotypes.  
 
 
 
  19 
Table 2.1: Comparison of Contractile and Synthetic Phenotypes
29,32,38
 
Contractile Phenotype Synthetic Phenotype 
Mature, differentiated  Dedifferentiated  
Elongated, spindle-shaped Rhomboid, triangular shaped 
Low rates of proliferation and migration High rates of proliferation and migration 
Secrete minimal amounts of ECM proteins Secrete large amounts of ECM proteins 
Contract, regulate blood flow Minimal contractile function  
Express contractile protein markers Do not express contractile protein markers  
 
2.3 CLINICAL SIGNIFICANCE  
 The leading cause of death both worldwide and in the U.S. is heart disease
39
. 
Heart disease includes stroke, arrhythmias, and cardiovascular diseases, such as 
atherosclerosis, hypertension, and restenosis
39
. Worldwide, approximately one in three 
deaths are attributed to cardiovascular disease
38
. The main risk factors for cardiovascular 
disease are smoking, hypertension (high blood pressure), diet, lifestyle and exercise
38
. 
Atherosclerosis is a vascular disease characterized by the accumulation of plaque and 
lipids in blood vessels, leading to vessel occlusion and more serious consequences such 
as myocardial infarction or stroke
40
. Restenosis is the narrowing of a blood vessel that 
occurs in response to a vascular injury received during a surgical procedure, such as an 
angioplasty
32
. Abnormal vascular smooth muscle cells contribute to the development of 
these cardiovascular diseases
27
.  
 The characteristic proliferative and migratory functions of synthetic vascular 
smooth muscle cells contribute to the development of many cardiovascular diseases, 
including atherosclerosis, hypertension, and restenosis. The current paradigm for 
cardiovascular disease development is based on VSMC plasticity and the ability for cells 
to switch to the synthetic phenotype and remodel the extracellular matrix
11
. It has also 
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been suggested that the activation of vascular stem cells present in the tunica media 
coupled with VSMC dedifferentiation could contribute to the development of 
cardiovascular disease
11
. Mechanical forces in blood vessels can be altered due to various 
factors, including hypertension, and this leads to the development of vascular smooth 
muscle cell pathophysiology
23
. On a cellular level, phenotypic switching of VSMCs to 
the synthetic phenotype is characteristic of the development of atherosclerosis in blood 
vessels
37
. Additionally, diseased vessels have changing mechanical signaling, cellular 
interactions, growth factors, and biochemical and inflammatory signals, which promote 
the synthetic phenotype (Figure 2.13)
37,36
. Synthetic VSMCs are able to synthesize more 
extracellular matrix proteins, leading to arterial stiffening and plaque accumulation in 
vessels
11
. 
 
Figure 2.13: Factors Promoting Synthetic VSMC Phenotype in Vascular Disease Development
36
 
 The cellular pathology associated with the development of atherosclerosis is 
endothelial cell dysfunction and vascular smooth muscle cell phenotypic modulation
38
. 
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Atherosclerotic lesion development involves several cell types including endothelial 
cells, macrophages, platelets, lymphocytes, and vascular smooth muscle cells (Figure 
2.14). In brief, endothelial cell dysfunction allows a lipid layer to accumulate, attracting 
macrophages that transition into foam cells. This leads to the formation of a lipid core in 
the intimal layer of the blood vessel, eventually inducing phenotypic modulation of 
vascular smooth muscle cells to the synthetic phenotype
38
. The combination of these 
mechanical, biochemical, and cellular interactions causes VSMCs to dedifferentiate into 
the synthetic phenotype. Synthetic VSMCs then produce enough extracellular matrix 
proteins to form the fibrous cap of a plaque in a diseased vessel
32
. In restenosis, VSMCs 
either undergo trauma or the surrounding endothelial cells are destroyed
32,40
. Then, 
VSMCs will migrate, proliferate, and secrete ECM proteins, contributing to the intimal 
lesions associated with restenosis
32
. Unfortunately, in the presence of certain risk factors 
and biochemical signals, vascular smooth muscle cells adopt functions that further the 
development of vascular disease
40
. In conclusion, the development of vascular diseases 
demonstrates the complexity associated with the vascular environment and cellular 
regulation
32
.   
 
Figure 2.14: Cell types involved in atherosclerotic fatty streak development
38
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2.4 MATERIALS AND METHODS  
2.4.1. Vascular Smooth Muscle Cell Culture  
 Adult Human Aortic Vascular Smooth Muscle cells (HAOSMCs) were purchased 
from Cell Applications, Inc. (Cat. 354pk-05a).  HAOSMCs were cultured in polystyrene 
flasks in standard cell culturing conditions (37°C, 5% CO2), using smooth muscle cell 
growth medium (Cell Applications, Inc.). First, frozen cells were thawed by warming a 
cryogenic vial of frozen cells retrieved from a liquid nitrogen tank. The frozen cell 
suspension was centrifuged with warmed media in a 15 mL centrifuge tube at 1,000 rpm 
for 5 minutes, and a cell pellet formed at the bottom of the tube. The supernatant was 
removed, cells were vortexed with 1 mL of media, and cells were then plated. Cells were 
passaged by first removing media and adding 0.25% Trypsin (Mediatech, Inc.) for 5-7 
minutes to allow the cells to detach from the flask surface. An equal amount of media 
was added to the trypsin/ cell solution to counteract the toxic effects of trypsin. The 
trypsin/media solution was centrifuged for 5 minutes at 1,000 rpm, leaving a cell pellet at 
the bottom of the centrifuge tube. The supernatant was then removed, and remaining cell 
pellet was vortexed with 1 mL media. To count cells, 20 μL of the original 1 mL cell 
suspension and 20 μL of Trypan blue dye solution (Sigma) were added to 160 μL of 
media. 20 μL of the dye solution was added to a hemocytometer, and cells were counted 
using the hemocytometer grid. Images of cells were taken using an Olympus CKX41 
microscope with Q-Imaging Software (Figure 2.15). Detailed cell culture protocols are 
available in Appendix A-B.   
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Figure 2.15: Human Aortic Smooth Muscle Cells in culture, passage 5, A. 10X, B. 20X  
 
2.4.2. Immunocytochemistry Staining  
 Immunocytochemistry staining is performed to stain a specific protein or cellular 
product using monoclonal primary antibodies that bind to the desired antigen. A 
fluorescent secondary antibody is then able to bind to the primary antibody to allow for 
visualization of the stain using a fluorescent microscope. Staining was performed 
separately for the following primary antibodies: Collagen Type 1 (Figure 2.18), alpha- 
smooth muscle actin (Figure 2.19), and alpha- smooth muscle actinin (Figure 2.20). 
Additionally, phalloidin staining was performed to visualize the actin cytoskeleton of the 
cell using either Alexa Fluor Phalloidin 568 (Invitrogen) or ActinGreen 488 (Life 
Technologies), (Figures 2.16- 2.17). Finally, the nucleus of the cell was stained with 
DAPI (Invitrogen).  
 In brief, cells were fixed with a 4% formaldehyde (Sigma), 0.1% glutaraldehyde 
(Polysciences, Inc.) solution at room temperature for 20 minutes. Cells were 
permeabilized with a 0.1% Triton X-100 (Sigma) solution at room temperature for 15 
minutes. Cells were then blocked in a 2% BSA (Rockland), 3% goat serum (MP 
Biomedicals) blocking solution at room temperature for 30 minutes. Cells were rinsed 3 
A. B. 
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times with 1X PBS (Alfa Aesar) between every solution change. Next, the monoclonal 
primary antibody diluted in the goat serum blocking solution was added and incubated at 
4°C overnight. Mouse anti-collagen type 1 (Sigma) was added at a dilution of 1:500, 
mouse anti-alpha smooth muscle actin (Sigma) was added at a dilution of 1:200, and 
mouse anti-alpha smooth muscle actinin (Hybridoma Bank) was added at a dilution of 3 
μg/mL. The secondary antibody, goat anti-mouse Alexa Fluor 488 (Invitrogen, green) 
was added at a concentration of 4 μL/mL for 2 hours at room temperature. Alexa Fluor 
568 Phalloidin (Invitrogen, red) was added at a concentration of 2.5% in 1X PBS for 20 
minutes at room temperature. 300 nM DAPI (Invitrogen, blue) was added for 5 minutes 
at room temperature. Images were taken using an EVOS fluorescent microscope.  
    
Figure 2.16: ICC staining of VSMCs for cytoskeleton with phalloidin (red) and nuclei with DAPI 
(blue), A. 10X, B. 20X 
    
Figure 2.17: ICC staining of VSMCs for cytoskeleton with ActinGreen 488 and nuclei with DAPI 
(blue), A. 10X, B. 20X 
A.  
A.  
B.  
B.  
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Figure 2.18: ICC staining of VSMCs for Collagen Type 1 (green) and nuclei with DAPI (blue),           
A. 10X, B. 20X 
 
    
Figure 2.19: ICC staining of VSMCs for alpha-smooth muscle actin (green) and nuclei with DAPI 
(blue), A. 10X, B. 20X 
 
        
Figure 2.20: ICC staining of VSMCs for alpha-smooth muscle actinin (green) and nuclei with DAPI 
(blue), A. 10X, B. 20X 
 
 
 
 
A.  B.  
B.  
B.  
A.  
A.  
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CHAPTER THREE 
MICROPATTERNING TECHNIQUES AND CELLULAR RESPONSES  
 
3.1 MICROPATTERNING TECHNIQUES  
3.1.1 Microfabrication  
 Microfabrication is the process of manufacturing structures on the micrometer 
scale, allowing for precision and incredible detail
1
.  Originally used in microelectronic 
applications, microfabrication techniques have since been adapted to create systems and 
structures used in biological and cellular studies
1,2
. Using micro-electromechanical 
systems (MEMS) in combination with biological and molecular elements allows for 
developments such as biomolecular sensors that are able to recognize and respond to 
chemical changes, cell-based assays, and controlled drug delivery devices that release 
therapeutic drugs based on environmental signals
1,2
.  
3.1.2 Micropatterning  
 Micropatterning is a microfabrication technique specifically focused on the 
controlled localization of biomolecules to create a patterned substrate for cell adhesion
1,3
. 
The first cell patterning took place in the 1960’s by S.B. Carter’s lab, with the intent of 
manipulating cellular environments to perform more controlled experiments in studying 
cell motility
4,5
. The general purpose of micropatterning is to develop a local 
microenvironment that promotes cell adhesion in a desired geometry
1
. Cell behavior is 
guided by elements of the surrounding environment: the substrate material, extracellular 
matrix proteins, and even neighboring cells
1
. These chemical, biological, and physical 
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parameters alter internal cell signaling pathways, influencing the resulting cellular 
responses
6
. Therefore, guiding cells into a particular orientation or pattern allows for the 
manipulation of cellular processes and interactions
6
.  
 Micropatterning is beneficial in that it enables studies on cellular interactions with 
their environment
1
. Patterned configurations can represent various environmental 
conditions, which allows for analysis of single-cell, multi-cell, and in vivo-like 
configurations
1
. Single cell micropatterning offers insights to cytoskeletal and organelle 
organization, individual cellular processes, and even cell-cell communication
3
. 
Additionally, micropatterning allows microscale studies on cellular behavior and cell-cell 
interactions with limited external factors. Successful micropatterning is characterized  not 
only by cell adhesion onto the patterned biomolecule, but also by minimal cell adhesion 
on the non-patterned surface
3
. A variety of micropatterning techniques, including 
photolithography and soft lithography, are employed to create a desired two-dimensional 
cellular microenvironment. It should be noted that due to constraints and requirements, 
substrate, biomolecule, and cell type choices must be optimized for their specific 
application, as there is no universal protocol
3
.  
3.1.3 Photolithography 
 Photolithography is a process used to transfer images from a photomask to a rigid 
surface using UV light exposure
2
.  A photomask is a transparent sheet made of glass or 
plastic, with high resolution patterns represented by the opaque and transparent regions
2
. 
During photolithography, geometric patterns are transferred to a silicon wafer serving as 
the master to form topographical features from a photoresist polymer (Figure 3.1)
1
.  First, 
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a light sensitive photoresist polymer is spin-coated onto the wafer
1
. The wafer is baked to 
allow for hardening of the photoresist. To transfer the pattern, the wafer is exposed to UV 
light through the transparent regions of photomask, allowing select patterns to be 
irradiated
1,2
. The photoresist-covered wafer is baked again and undergoes a development 
process to remove excess photoresist
1
. The photoresist will either become soluble or 
insoluble after being illuminated with UV light
6
. Positive photoresist becomes soluble 
when exposed to UV light and can be removed with photoresist developer, leaving 
structures representative of the transparent pattern of the photomask
2
.  Conversely, 
negative photoresist becomes crosslinked and insoluble upon exposure to UV light, 
remaining as raised structures on the wafer as the photoresist developer removes the 
unexposed photoresist and producing the inverse of the photomask pattern
2
. The most 
widely used photoresist in photolithography applications is SU-8, a negative photoresist, 
by MicroChem Corporation
2
. An advantage of using photolithography is that high 
resolution patterns can be achieved, and patterned silicon wafers can be stored long-
term
2,6
. However, photolithography requires expensive materials as well as processing in 
a clean room environment
2,6
.  
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 Figure 3.1: Process of photolithography to create a master silicon wafer for both positive and 
negative photoresists
2
  
3.1.4 Soft Lithography 
 Adapted from photolithography, soft lithography is a process that uses an 
elastomeric, or “soft”, material to transfer patterns to a surface2. Generally, an elastic 
stamp or mold is created from a master silicon wafer produced by photolithography. An 
elastomeric polymer is cast over the master wafer, is cured or hardened, and the desired 
stamps can then be removed from the master
1
.  PDMS, or poly(dimethyl)-siloxane, is the 
most commonly used polymer to make elastomeric stamps, molds, and stencils, although 
other siloxanes can also be used
1
. PDMS is hydrophobic, transparent, biocompatible, and 
possesses good thermal and mechanical characteristics. PDMS is low cost and easy to 
use, making it a strong stamp material choice
5,7
.  The stamps or molds can then be used to 
pattern biomolecules onto a receiving surface
6
.  The three most commonly used soft 
lithography techniques are microstamping, microfluidic patterning, and stencil patterning 
(Figure 3.2)
2
.  
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Figure 3.2: Soft lithography techniques: microfluidic patterning, microstamping, and stencil 
patterning
2
 
3.1.5 Microstamping 
 Microstamping, or micro-contact printing (μCP), is the most commonly used 
micropatterning method for cell patterning applications
1
. Microstamping is based on the 
contact-transfer of biomolecules or organic molecules from stamps onto a receiving 
surface
2. Biomolecules are first “inked” onto the surface of a PDMS stamp and are then 
“stamped” or “printed” onto the receiving surface through the process of surface 
adsorption
2,6. A “backfilling” procedure can be performed to restrict cell adhesion to the 
pattern and reduce cell spreading (Figure 3.3)
1
. Backfilling prevents protein absorption 
by modifying the surface chemistry of the substrate through the addition of a molecule or 
chemical to become non-reactive. Advantages of microstamping are ease of use, low 
cost, and the ability to customize and reuse stamps
1
. Limitations of this method are 
pattern size constraints as well as the tendency for cell spreading despite backfilling
3
.  
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Figure 3.3: Steps of microstamping: A, “Inking”, B. “Stamping”, C. Stamp removal, and D. 
Backfilling [modified from ref. 1]  
3.1.6 Microfluidic Patterning  
 Microfluidic patterning uses a PDMS mold with microchannels to form the 
desired pattern
2
. The mold is created from a master wafer to create a substrate with 
microchannels
1
. The mold adheres to the receiving surface due to the self-sealing 
properties of PDMS, and a biomolecule solution is flooded into the mold, with capillary 
forces drawing the solution through the channels
5,6
. The biomolecules will form a pattern 
in the regions where the PDMS substrate does not contact the surface (Figure 3.4)
1
. An 
advantage of this method is that parallel microchannels allow for patterning of several 
biomolecules simultaneously, enabling complex studies on cellular interactions with 
varied molecules
1
. However, patterns are limited to open network, continuous geometries 
which must be large enough to allow for fluid flow underneath the mold
2,6
.  
A.  
B.  
C.  
D.  
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Figure 3.4: Steps of microfluidic patterning: A. Mold placed on substrate, B. Biomolecules flow 
through microchannels of the mold, C. Mold removal, D. Backfilling [modified from ref. 1]  
 
3.1.7 Stencil Patterning   
 Stencil patterning uses a template or stencil so that cells can be seeded directly 
onto the receiving surface in the desired pattern
5
. PDMS stencils can be produced from a 
master wafer, with the pattern representing the inverse of the master
8
. Laser ablation can 
be used to create precise geometric stencils from a polymer film
9
. Generally the stencil is 
placed onto the substrate, cells are seeded, and the stencils are removed once cells have 
adhered to the surface
9
. An alternative method is plasma stenciling, which is based on 
surface activation to produce hydrophilic, cell-adhesive regions
10
. Plasma stenciling 
employs a PDMS stencil to direct plasma activation of the substrate surface, creating the 
hydrophilic regions for preferential cell adhesion
10
. Stencil patterning has been shown to 
produce more controlled, localized patterns of cell alignment compared to other 
micropatterning techniques
9
. Advantages of this method include ease of use, stencil 
biocompatibility, and a range of possible pattern designs
8
. Additionally, cells can be 
directly seeded onto the substrate without a protein pattern or backfilling procedure.  
 
A.  
B.  
C.  
D.  
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3.1.8 Considerations for Soft Lithography  
 “Backfilling” is an additional process used to prevent cells from adhering to the 
background regions of a micropatterned surface
1
. After biomolecules are patterned and 
the remaining surface is backfilled, cells can be plated onto the substrate. Backfilling is 
achieved by using nontoxic, anti-adhesive molecules, such as Pluronics, to reduce 
unwanted cell adhesion and spreading
11
. Pluronics are triblock surfactants that prevent 
protein adsorption on a hydrophobic surface
12
. ECM protein patterns can become 
compromised when exposed to cells in a culture medium
13
. Proteins in the culture 
medium adsorb to a substrate surface, allowing non-specific cell adhesion and rendering 
the patterned proteins irrelevant
13,14
. Further, a study showed that culturing cells on 
collagen results in increased cell spreading due to cell-ECM interactions, confirming the 
necessity of a more effective anti-adhesive method
12
. Pluronics mitigate this issue by 
preventing both protein adsorption and cell adhesion on non-patterned hydrophobic 
surfaces
12
. Pluronics are commonly used because they are effective and low cost, 
although they might require additionally surface chemistry procedures and are only stable 
for short-term storage
3
.  
 Soft lithography is an advantageous process because of its immense flexibility in 
substrate and molecule selections. Many molecules can be patterned, including 
extracellular matrix proteins (collagen, laminin, fibronectin), peptides, polysaccharides, 
lipids, and antibodies
2
. Additionally, stamps and molds are reusable, easy to produce, and 
less expensive than photolithography methods
1
. However, most soft lithography methods 
still require a master produced by photolithography
2
. There are size and resolution 
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constraints depending on the method used, as well as limited pattern geometries
1
. 
Depending on the cell type, cells are capable of attaching to backfilled or passivated 
regions of the substrate, although in lower quantities than in the protein-covered 
patterns
3
. Cells are also able to detach from protein patterns, thus remodeling or 
degrading the protein pattern. Overall, optimization of soft lithography methods is 
required for successful patterning based on experimental specifications
3
.  
   
3.2 THE EXTRACELLULAR MATRIX AND CELLULAR RESPONSES  
3.2.1 Cellular Microenvironments and the Role of the Extracellular Matrix  
 The microenvironment of a cell is imperative for regulation and homeostasis of 
cellular processes: cells sense and respond to the signals in their environment
7,15
.  The 
extracellular matrix (ECM) forms the non-cellular, structural framework on which cells 
adhere and establish tissue organization
7,15
. The ECM has both physical characteristics 
(topographical features, mechanical stiffness) and molecular organization (ECM protein 
composition) that provide signaling cues to cells
7
. ECM proteins have both nanometer 
and micron-level structures that influence various aspects of cellular behavior
16
. Contact 
guidance describes the phenomenon in which cells respond to the external signals 
received from interactions with the ECM
16
.   
 Common fibrous ECM proteins are collagen, elastin, laminin, and fibronectin; 
each contributes to specific cellular behaviors
17
. Collagen is the most abundant ECM 
protein in the body, and it is important in providing structural support
18
. Collagen fibers 
are highly organized, with a triple helix of collagen molecules forming the fibrils that are 
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intertwined to form functional fibers
18
. Collagen provides tensile strength throughout 
tissues, and it plays a role in regulating cell adhesion and migration
15
. Elastin provides 
elastic recoil in tissues that experience constant deformation, allowing tissues to stretch 
and recover without permanent damage or impairment
15,18
. Fibronectin is an adhesive 
protein that not only organizes the matrix but also enables cell adhesion and 
attachment
15,18
. Laminin is a fibrous protein important in connecting the plasma 
membrane to the surrounding ECM network, facilitating cell signaling
19
.  
3.2.2 Cellular Responses to Micropatterning  
 Micropatterning allows for precise construction of an extracellular matrix that 
mimics the native microenvironment
7. Replicating the unique structure of a cell’s ECM 
facilitates studies on the interactions between a cell and its environment, providing 
insight on cell behaviors, cell mechanics, and the internal cell processes of apoptosis and 
division
7
. Most cells, including vascular smooth muscle cells, are anchorage-dependent, 
requiring attachment to either an ECM surface or neighboring cells for survival
7
. Thus, it 
is important to understand how cells are affected by the contact guidance provided by the 
ECM.  
 Cell alignment is defined as the spatial arrangement of cells, and it affects many 
cellular functions including cell morphology, adhesion, migration, and proliferation
13
. 
Micropatterning allows for customized cell alignment. Depending on anatomical location 
and orientation, a specific pattern is chosen to construct an in vivo-like 
microenvironment
7
. For example, parallel lines mimic vascular smooth muscle cell 
alignment, while a diamond or lattice pattern provides a more natural arrangement for 
  39 
cardiomyocytes and cardiac fibroblasts
20
. Integrins are a cellular structure important in 
cell-ECM interactions, and the arrangement of the ECM influences the distribution of 
integrins throughout the cell
7
. Integrin quantity and placement can alter the organization 
of cytoskeletal elements, leading to overall changes in the morphology and structure of 
the cell
7
. A trend exhibited in many studies is that cells aligned on grooved topographies 
orient themselves in the direction of the groove, exhibiting an elongated phenotype due to 
altered microtubule and microfilament organization
21
.  
 Cell migration is almost entirely dependent on signals from the environment: a 
motogen induces cell migration to occur in a particular direction. ECM patterns can direct 
cell migration by changing the orientation of the internal cytoskeleton and motility 
structures
7
. Many cell types patterned in grooves or lines have displayed migration in the 
direction of alignment, along with increased migration rates
16
. Cell proliferation refers to 
the rate of increase of cell number. A trend seen in patterned cells is a decrease in 
proliferation rates, perhaps due to cytoskeletal structure or phenotype changes
13,16
. 
Additionally, patterning has been shown to alter gene expression, which can be used to 
manipulate cell differentiation
16
. It should be noted that cellular responses depend on 
many factors, including the size and geometry of ECM features as well as the cell type 
itself.  
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3.3 RESPONSE OF VASCULAR SMOOTH MUSCLE CELLS TO 
MICROPATTERNING  
3.3.1 Native Microenvironments of Vascular Smooth Muscle Cells   
 In a native blood vessel, vascular smooth muscle cells are circumferentially 
oriented in the tunica media layer
13
. VSMCs are surrounded by a dense ECM network 
composed of collagen fibers and helical bands of elastin (Figure 3.5)
13
. VSMCs are 
highly organized, and although they exhibit phenotype plasticity, they typically display a 
contractile phenotype with an elongated morphology
22
. In a healthy blood vessel, the 
contractile phenotype is associated with low proliferation rates
22
. The mechanical forces 
associated with blood flow induce the alignment of vascular smooth muscle cells as 
blood vessels form during angiogenesis
13
. The arrangement of VSMCs reflects their 
contractile function: the circumferential alignment allows for maximal contraction and 
relaxation with minimal fatigue
13
. It is likely that the native microenvironment, ECM 
arrangement, and tightly packed circumferential alignment of surrounding VSMCs 
enforces the contractile phenotype in a healthy vascular system
23,24
.  
 
Figure 3.5: VSMC circumferential alignment in a blood vessel [modified from ref. 13] 
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3.3.2 Motivation for Micropatterning Vascular Smooth Muscle Cells  
 The majority of VSMCs in vitro display a synthetic phenotype, with random 
organization and minimal alignment
23
. Additionally, the synthetic phenotype becomes 
more prevalent at higher passage numbers
23
. VSMCs at a higher seeding density are 
capable of switching to a contractile phenotype
25
. Understanding ECM-cell and cell-cell 
interactions in a micropatterned environment is important in regulating VSMC 
phenotype
25
.  Micropatterning can be used as a method to control VSMC phenotype by 
mimicking an in vivo environment
26
. This will allow for more controlled and uniform 
studies, as the two phenotypes are associated with two different sets of functions that 
could significantly affect experimental results
22
. Micropatterning methods can be used to 
explore how VSMC phenotypes and cell behaviors can be manipulated and maintained. 
This is essential in studying cell biology, disease states and progression, as well as in 
blood vessel tissue engineering applications
23
. Understanding how to promote phenotypes 
is important in establishing more controlled and accurate studies of vascular smooth 
muscle cells.  
3.3.3 Responses of Vascular Smooth Muscle Cells to Micropatterning  
 Despite a variety of micropatterning methods and specifications, there are several 
established trends noticed in micropatterned vascular smooth muscle cells. 
Micropatterning VSMCs has been shown to regulate cell morphology and shape, 
proliferation rates, phenotypic display, and cell spreading. Generally, micropatterning 
induces a more in vivo-like phenotype in VSMCs. VSMCs become more elongated, 
possibly due to the alignment mimicking their native environment
23
. Proliferation rates 
  42 
also decrease, possibly due to the limited ability to spread in the patterned environment
22
. 
Overall, the topography of the micropatterned surface can promote cell alignment and 
regulate many cellular functions. Studies have shown that patterning onto topographical 
grooves elicits the same response as micropatterned ECM proteins, suggesting the 
physical structures of the environment are responsible for phenotype changes in VSMCs. 
However, ECM proteins provide both physical and chemical cues that might enhance 
these phenotypic trends. Table 3.1 summarizes several studies investigating responses of 
vascular smooth muscle cells to micropatterning.  
Table 3.1: Summary of Vascular Smooth Muscle Cell Micropatterning Studies 
Author  Cell Type 
Patterning 
Method 
Specifications Results  
22
Thakar, et 
al. 2003 
Bovine 
aortic 
SMCs 
Microfluidic 
patterning  
20 μm collagen 
lanes  
Decreased cell shape index, 
spreading area, and 
proliferation rates  
23
Williams, 
et al. 2011 
Rabbit 
common 
carotid 
SMCs 
Microcontact 
printing 
20 μm comb 
polymer lanes 
Decreased cell shape index, 
increased elongation and 
alignment  
25
Cao, et al. 
2010 
Human 
aortic 
SMCs 
Microchannel 
Scaffolds 
300 μm wide 
microchannels  
Decreased ECM protein 
production, increased 
contractile protein 
expression 
24
Goessl, et 
al. 2000 
Rat 
vascular 
SMCs 
Plasma 
Lithography 
5 x 5 μm2 to 60 
X 60 μm2 
squares  
Maintained cell alignment, 
control of cell shape and 
size  
27
Thakar, et 
al. 2009 
Human 
aortic 
SMCs 
Microcontact 
printing 
10 μm 
fibronectin lanes  
Elongated morphology, 
decreased cell shape index, 
cell spreading, and 
proliferation rates  
28
Shen, et al. 
2006 
Rat aortic 
SMCs 
Micro-
patterning of 
polymeric 
grooves  
40- 160 μm 
microchannels  
Spindle-shape morphology, 
increased contractile 
protein expression and 
alignment  
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3.4 METHODS, RESULTS, DISCUSSION, AND FUTURE IMPROVEMENTS   
 The following section includes the methods and results for each step of the 
micropatterning process. A photomask was designed, which was used in 
photolithography to fabricate a master wafer. The master was then used in soft 
lithography processes to create stamps and molds. Three micropatterning processes were 
implemented: microstamping, microfluidic patterning, and stencil patterning. Results for 
each method are discussed, and recommendations for future improvements are included.  
3.4.1. Photomask Design  
 A photomask was designed using SolidWorks and was produced on high 
resolution transparency film by CAD/Art Services.  Several design factors were 
considered when designing the photomask, including master wafer and stamp size 
requirements, as well as pattern sizes and geometries dictated by the vascular smooth 
muscle cell type. Eleven stamp designs were produced on the photomask, and they were 
arranged in a circular layout with a diameter less than 7 cm to fit onto the silicon wafer 
during photolithography (Figure 3.6). The outer dimensions of each stamp design were 
set as 6 X 6 mm in order to fit into the 8 X 8 mm area of the cell stretcher well plates. 
Five patterns were parallel lines, and six patterns were diamonds. All lines were spaced 
300 μm apart to ensure sufficient spacing for cell alignment and to prevent cell crossover. 
Parallel lines were designed with varying widths: 10, 30, 50, 100, and 300 μm. Diamonds 
were designed with varied widths (30 or 100 μm) and angles of intersection (45°, 60°, 
and 90°). A legend of the photomask stamp designs along with the final proof is available 
in Appendix K.  
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Figure 3.6: SolidWorks drawing of photomask with eleven stamp designs 
3.4.2. Photolithography  
 Photolithography was used to fabricate the master wafer by transferring the 
patterns on the photomask to a photoresist-covered wafer using UV light exposure. 
Photolithography was performed in a clean room environment. In brief, a silicon wafer 
(University Wafer) was preheated on a hot plate at 95°C for 5 minutes, cleaned with 
isopropyl alcohol (IPA), and blown dry with nitrogen gas. The silicon wafer was placed 
on a spin-coater, and the vacuum was turned on to hold the wafer in place. SU-8 
photoresist (MicroChem Corp.) was added to the center of the wafer in an even layer. 
The photoresist was spin-coated onto the wafer at 500 rpm for 10 seconds, 3,000 rpm for 
30 seconds, and 500 rpm for 10 seconds to produce a photoresist thickness of 5 μm. The 
photoresist-coated wafer was soft baked at 95°C for 2 minutes. The UV controller and 
mask aligner were powered on, and the UV arc lamp was allowed to warm up for 10 
minutes. The UV exposure system was calibrated, and the intensity and exposure time 
were set on the UV controller. The photomask and wafer were placed into the mask 
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holder of the UV exposure system, which was secured in place. The wafer was exposed 
to UV light for a specified amount of time, baked at 95°C for 3 minutes, and allowed to 
cool. The photoresist was developed by rinsing the wafer with SU-8 developer 
(MicroChem Corp.). The wafer was rinsed with IPA, alternating between developer and 
IPA until excess photoresist was removed. Finally, the wafer was hard baked at 150°C 
for 30 minutes to crosslink the remaining photoresist features. Appendix F describes the 
full protocol of using photolithography to fabricate the master wafer.  
  
Figure 3.7: Photolithography results, A. Master silicon wafer, B. Diamond microstructures on wafer 
 The photolithography process was successful at transferring the stamp patterns 
onto the silicon wafer. Figure 3.7B shows the diamond microfeatures of the photoresist 
on the wafer.  
3.4.3. Soft Lithography  
 Before stamp fabrication, the master wafer was silanized. 50 μL of 
octyl(trichlorosilane) was added to a petri dish and placed inside a vacuum desiccator 
along with the master. The vacuum to the dessicator was applied for 20 minutes, and the 
master was stored in the desiccator overnight. To fabricate stamps, PDMS was prepared 
by mixing a Sylgard 184 base and curing agent in a 10:1 ratio for 10 minutes. The mixed 
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polymer was cast over the master in a petri dish and placed in a desiccator for 10 minutes 
to remove air bubbles. The master was baked on a hot plate for 1 hour at 70°C to allow 
the PDMS to fully harden. The PDMS was allowed to cool and was carefully removed 
from the petri dish and master wafer using a scalpel. The individual stamps were then cut 
from the PDMS sheet and stored pattern side-up (Figure 3.8, 3.9, and 3.10).   
 
Figure 3.8: PDMS stamps  
  
Figure 3.9: Schematic of PDMS stamps, A. Line pattern, B. Diamond pattern (not shown to scale) 
 
  
A. B. 
A. B. 
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Figure 3.10: Microstructures on PDMS stamps, A. 30 μm lines, B. 100 μm lines, C. 100 μm, 90° 
diamonds, D. 100 μm 45° diamonds (10X) 
 PDMS stamps with handles were fabricated for ease of use in patterning. 2 X 2 X 
20 mm handles were designed in SolidWorks and 3D printed at the Watt Center 
MakerSpace. A compatible stamp holder was printed to hold the stamps with handles 
upside-down during the “inking” process of microstamping. A thin layer of PDMS was 
cast over the master and allowed to cure. Another layer of PDMS was cast over the initial 
layer, and the handles were arranged on top of the master patterns. The second layer of 
PDMS was allowed to cure, and the individual stamps were cut out. While some handles 
were aligned, it was difficult to accurately position the handles directly above each 
pattern. Additionally, handles did not stand upright in the liquid PDMS, and thus did not 
dry completely upright. As a result, stamping was inefficient due to the unequal contact 
of the stamp to the surface. Efforts to attach handles to the PDMS stamps separately 
included hot glue, super glue, and liquid PDMS, but all were unsuccessful at providing a 
secure, durable attachment for both sterilization and stamping procedures. In the future, a 
system that directly aligns and holds the handles in place above the wafer would be 
effective in positioning the handles in the PDMS. Handles would allow for easier 
handling of stamps during the stamping process (Figures 3.11, 3.12, and 3.13).  
C. D. 
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Figure 3.11: 3D-printed stamp handles  
  
Figure 3.12: Schematic of stamp with attached 3D-printed handle (not shown to scale) 
 
  
Figure 3.13:  PDMS stamps with handles, A. Stamp and handle assembly, B. Stamp holder  
3.4.4. Microstamping  
 Successful microstamping was achieved through optimization of various 
parameters, including the duration of “inking” and “stamping”, method of collagen 
removal after “inking”, drying of collagen, substrate materials, and weight applied to the 
A. B. 
  49 
stamp. A successful protocol is described in Appendix H and is summarized here. PDMS 
stamps were sterilized in 100% ethanol and sonicated for 15 minutes in an ultrasonic 
cleaner (VWR International). Stamps were rinsed with ethanol and allowed to dry. 
Stamps were “inked” for 1 hour by adding 100 μL of 100 μg/mL collagen to the 
patterned side of the stamp. At the same time, the stamping substrate, either the silicone-
based well plate for the cell stretcher or a PDMS gel, was placed in a UV-ozone chamber 
for 15 minutes. The collagen was removed from the stamp, and the stamp was rinsed 
twice with 1X PBS and allowed to dry completely. The rinse and dry method produced 
better collagen edges with minimal distortion compared to drying the collagen with a 
nitrogen gun. The stamps were then placed onto the stamping substrate for 30 minutes. 
Best results were seen when only the edges of the stamp were pressed gently with 
tweezers to ensure initial contact, with no additional pressure placed on the stamp (Figure 
3.14). Images of collagen patterns were taken using an Olympus CKX41 microscope. 
Images of unsuccessful stamping trials are in Appendix L.  
  
Figure 3.14: Successful collagen microstamping on PDMS gel, A. 90°, B. 60° diamonds (10X)  
  
 
A.  B.  
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3.4.5 Pluronic Solutions to Eliminate Non-Specific VSMC Adhesion  
 A Pluronic solution was employed to promote cell adhesion specifically on the 
collagen while reducing cell spreading off of the pattern. A 1% Pluronic-125 (Sigma) 
solution was made in millipore water. The Pluronic solution was added either before or 
after microstamping and was incubated at room temperature for 1 hour.  The surface was 
rinsed 3 times with 1X PBS. VSMCs were plated and incubated for 24 hours. VSMCs 
were fixed in a 4% formaldehyde (Sigma), 0.1% glutaraldehyde (Polysciences, Inc.) 
solution for 20 minutes, followed by a 0.1% Triton X-100 (Sigma) solution for 15 
minutes to permeabilize the cells. ActinGreen 488 (Life Technologies) was added for 30 
minutes to stain the cytoskeleton, and 300 nM DAPI (Invitrogen) was added for 5 
minutes to stain the nuclei.  
4X 10X 
  
  
  
A.  B.  
C.  D.  
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Figure 3.15: Microstamped collagen with Pluronic solution, A, B. Control, C, D. Pluronic added 
before stamping, E, F. Pluronic added after stamping  
 Figure 3.15 A-B show the control VSMCs randomly oriented with no preferential 
attachment to the collagen pattern. When the Pluronic solution was added before 
microstamping, the collagen pattern was preserved (Figure 3.15 C-D). Significant cell 
spreading and overlapping of lanes still occurred. When the Pluronic solution was added 
after microstamping, it possibly altered the collagen pattern, leaving groupings of cell 
adhesion (Figure 3.15 E-F). The addition of the Pluronic solution did decrease cell 
adhesion directly to the petri dish, although there was still some undesired cell spreading. 
The Pluronic solution did not promote cell alignment onto the pattern significantly 
compared to the control. Overall, the Pluronic solution did not provide the parallel cell 
alignment desired.  
3.4.6 Microfluidic Patterning  
 PDMS stamps with parallel lines used for microstamping were modified to have 
open channels on two opposite sides, thus forming a mold with microchannels (Figure 
3.16). The molds were placed pattern-down onto a petri dish so the pattern made direct 
contact with the substrate, leaving 300 μm gaps. A cell suspension was then flooded 
through the channels to promote cell adhesion along the open surface left by the 
E.  F.  
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microchannels. Cells did adhere to the petri dish, but not many cells were able to travel 
through the microchannels. It is possible that the height of the mold was not tall enough 
to allow for proper fluid flow through the microchannels, or that the cell suspension was 
not properly flushed through the channels. In the future, a mold with taller features would 
likely be more successful at aligning cells, which could be achieved by molding PDMS to 
a master with taller photoresist features.   
 
Figure 3.16: Schematic of microfluidic patterning mold (not shown to scale)  
3.4.7 Stencil Patterning  
 The next type of micropatterning attempted was stencil patterning.  As a proof of 
concept, 7 X 7 mm stencils were cut from a cured PDMS sheet approximately 2 mm 
thick. Two 1-mm channels were cut to form the negative space of the stencil (Figure 
3.17). Stencils were firmly pressed against a petri dish surface, and cells were seeded and 
allowed to incubate for 24 hours. Cells were fixed, permeabilized, and stained with Alexa 
Fluor 568 Phalloidin (Thermo Fisher Scientific) for the cytoskeleton and DAPI 
(Invitrogen) for the nuclei.  
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Figure 3.17: Stencils: A, Schematic of stencil patterning stencil template (not drawn to scale),  
B. PDMS stencils 
 
  
Figure 3.18: A, B. Stencil patterning of VSMCs stained with Phalloidin (red) and DAPI (blue) (4X) 
 Stencil patterning was successful in aligning VSMCs. Cells adhered to the 
negative space of the stencil, although there was some cell spreading underneath the 
stencil (Figure 3.18). This could be improved by more precisely fabricating the stencils 
to have completely flat surfaces. Stencil patterning onto the silicone surfaces seemed to 
be the most effective micropatterning method for VSMC alignment. 
 
 
 
 
 
 
A.  B.  
A.  B.  
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CHAPTER FOUR 
STRETCHED TO THE LIMIT: CELL STRETCHING 
 
4.1 CELL STRETCHING DEVICES  
4.1.1 Device Specifications and Experimental Parameters  
 Cell stretching devices are research tools employed in studying the effects of 
mechanical conditions on cell behaviors
1
. The development of cell stretching devices that 
realistically represent healthy or pathological conditions is important to accurately 
represent the mechanical environment cells experience in vivo
1
. There are many types of 
cell stretching devices, ranging from commercially available to custom-made. 
Commercially available devices include the Flexcell (Flexcell International), 
ElectroForce (Bose), Strex (B-Bridge International), and MechanoCulture FX 
(CellScale)
2
. Both 2D and 3D stretching environments are available, and Figure 4.1 
shows the possible mechanisms of stretch for 2D uniaxial devices.  
 
Figure 4.1: Mechanisms of 2D uniaxial stretch: A, Pneumatic, B. Electromechanical clamp-arm, C. 
Cantilever bending [modified from ref. 2]  
 Cell stretching devices have many adjustable parameters, including stress/ strain 
magnitude, rate of force application, stretch direction/orientation, stretch regimen, 
frequency, and duration
1,2
. The stretch regimen can be uniaxial, biaxial, or radial 
stretching, each of which have characteristic effects on cells
1
. For example, uniaxial 
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stretching has been shown to align cells in a specific orientation
1
.  Surface and EMC 
interactions with the tested cell type can affect the overall results
2
. Additionally, 
patterning cells may cause variations in the amount of strain applied to the substrate and 
subsequently received by the cells
2
. While commercially available cell stretching devices 
have limited customizable parameters, they are very useful because they have known 
properties, strain profiles, and stretch regimens. The inherent differences between devices 
and the settings used can have great effects on mechanical cues the tested cells actually 
receive, so it is important to use a well-characterized device
2
. Using commercial 
stretching devices provides a uniform way to study mechanical conditions, generating 
scientific results that can be compared more easily.  
4.1.2 The MechanoCulture FX Cell Stretching Device   
 The MechanoCulture FX by CellScale is a mechanical stimulation system that 
produces cyclic uniaxial stretch across a well plate using a clamp-arm system
3
 (Figure 
4.2). Customizable test parameters include linear or sinusoidal velocity, stretch 
magnitude (percent axial strain), frequency, rest periods, repetitions, and duration of the 
stretching program
3
. A specialized silicone well plate is utilized by the MechanoCulture 
FX to provide uniform axial stretch to each well. Further, the device components can be 
sterilized with UV light or autoclave methods, ensuring sterility and compatibility with 
cell culture environments. The MechanoCulture FX has been used to study the effects of 
cyclic strain on cell and ECM fiber alignment
4,5
.  
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Figure 4.2: MechnoCulture FX System, A. Specialized well plate, B. Cell Stretching Device
3
 
 
4.2. MECHANOTRANSDUCTION  
 Mechanotransduction is the process by which external, mechanical signals are 
converted to biochemical signals that influence intracellular responses
6
. External 
mechanical stimuli induce a cascade of cellular processes imperative for the regulation of 
a cell’s homeostatic activities1. Mechanical signaling regulates many cellular functions, 
including differentiation, migration, gene expression, and adhesion
7
. The cytoskeleton of 
a cell is viscoelastic, capable of withstanding mechanical forces, and it is heavily 
involved in distributing the mechanical signals enforced upon the cell. Mechanoreceptors, 
including integrins and protein kinases, are found in both the cytoskeleton and cell 
membrane, and they are the receptors that convert the initial physical stimulus into a 
biochemical signal
8
.  
 
 
 
A. B. 
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4.3 EFFECTS OF STRETCHING VASCULAR SMOOTH MUSCLE CELLS  
 VSMCs are constantly exposed to mechanical signaling from the shear stress and 
pressure on the blood vessel wall caused by the pulsatile flow of blood through 
vasculature. Continuous mechanical signaling is necessary to maintain the healthy, 
contractile functioning of VSMCs
9
. Abnormal mechanical forces are associated with the 
transition of contractile VSMCs to the synthetic phenotype. The presence of synthetic 
VSMCs is indicative of many vascular diseases, including atherosclerosis and 
hypertension
9,10
. Understanding how mechanical forces influence tissue and cell behavior 
will advance clinical therapeutics and diagnostics, as well as lead to a better general 
understanding of vascular pathology at the cellular level.  Cell stretching devices are used 
to not only study the effects of mechanical forces on the pathogenesis of VSMCs, but 
also to create disease state models to test potential therapeutics for vascular disease
7
. 
 
4.4 METHODS, RESULTS, AND DISCUSSION  
 Three stretching experiments were performed to determine the effect of a 
physiologically relevant stretching regimen on aligned vascular smooth muscle cells:  
 1) VSMCs on microstamped collagen patterns 
 2) Stencil patterned VSMCs (Trial 1) 
 3) Stencil patterned VSMCs (Trial 2) 
The methods and results for each of these three experiments are discussed below.   
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4.4.1 Stretching VSMCs on Microstamped Collagen Patterns – Methods  
 To determine the effect of cyclic stretching on cell phenotype, VSMCs were 
plated onto microstamped collagen patterns using PDMS stamps. The MechanoCulture 
FX Mechanical Stimulation System, Version 1, by CellScale was used as the cell 
stretching system. 
 
Figure 4.3: Overview of methods of microstamping collagen and stretching VSMCs 
 
 Specialized silicone well plates custom for the MechanoCulture FX System were 
sterilized in 100% ethanol and UV light for 30 minutes (Figure 4.4). PDMS stamps were 
sterilized in 100% ethanol by sonicating for 15 minutes in an ultrasonic cleaner (VWR 
International). The experimental plate was secured in the well plate holder of the 
sterilized cell stretching system. Collagen was stamped onto the well plates using both 
line and diamond patterns (stamps #2, 5, 7, and 8, as seen in Table K-1), following the 
methods described in Chapter 3.4.4. VSMCs were passaged using 0.25% Trypsin 
(Mediatech, Corning) and plated at a density of 20,000 cells per well. VSMCs were 
removed after 30 minutes to improve cell adhesion directly onto the collagen pattern. The 
MechanoCulture FX control box was programmed with a set of pre-conditioning steps 
along with a stretch representative of normal blood vessel physiology for a duration of 24 
hours (Table 4.1). A stretch regimen of 5% axial strain at 1 Hz was used to represent 
healthy vascular physiology. Complete programming screen display of the 
MechanoCulture FX software is available in Appendix M.  The control box was 
Sterilize Well-plates Stamp Collagen Plate VSMCs Stretch Stain 
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programmed, plugged into a power source, and connected to the cell stretching system in 
the incubator. To begin cell stretching, the button on the control box was pressed once.  
 After the stretching sequence was completed, VSMCs were stained. First, cells 
were fixed with a 4% formaldehyde (Sigma), 0.1% glutaraldehyde (Polysciences, Inc.) 
solution at room temperature for 20 minutes. Cells were permeabilized with a 0.1% 
Triton X-100 (Sigma) solution at room temperature for 15 minutes.  Alexa Fluor 568 
Phalloidin (Thermo Fisher Scientific) was added at a concentration of 2.5% in PBS for 20 
minutes at room temperature to stain for the actin cytoskeleton of the cell. 300 nM DAPI 
(Thermo Fisher Scientific) was added for 5 minutes at room temperature to stain for cell 
nuclei. Cells were rinsed three times with 1X PBS (Alfa Aesar) between every solution 
change. 1X PBS was added to the stained wells for storage. Images were taken using the 
EVOS microscope.  
 
Table 4.1: Program sequence for stretching VSMCs on microstamped collagen 
patterns  
Step of Program 
Sequence  
Strain 
(%) 
Stretch 
Displacement 
(mm) 
Frequency 
(Hz)  
Stretch/ 
Recovery 
Duration (s) 
Total Step 
Duration 
(s) 
Initial Stretch - 0.5 - 10.0/ 0.0 10  
Pre-Conditioning 1 0.1333 0.1 5.0/ 5.0  900  
Pre-Conditioning 1 0.1333 0.5 1.0/ 1.0 900  
Pre-Conditioning 1 0.1333 1 0.5/ 0.5 900  
Pre-Conditioning 2.5 0.3333 1 0.5/ 0.5  900 
Heart Physiology  5 0.6666 1 0.5 /0.5 86,400 
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Figure 4.4: MechanoCulture FX cell stretching system A. Well plate holder, B. Specialized silicone 
24- well plate for the MechanoCulture FX
3
  
 
4.4.2 Stretching VSMCs on Microstamped Collagen Patterns – Results and Discussion   
  
Figure 4.5: Visible collagen patterns (4X), A. 100 μm collagen lines (stamp #5) B. 30 μm collagen 
diamonds (stamp #7) 
 
 Under light microscopy, collagen patterns are visible on the silicone well plate. 
Figure 4.5A shows 100 μm collagen lines patterned using Stamp #5, and Figure 4.5B 
shows 30 μm collagen diamonds patterned using Stamp #7. While the collagen patterns 
are visible, the silicone well plate does not allow for visualization of VSMCs due to their 
naturally thin, flattened structure.  
A. B. 
A. B. 
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Figure 4.6: VSMCs stained for phalloidin (10X), A. Control VSMCs, B. Stretched VSMCs 
 
 VSMCs did not appear to adhere specifically to the collagen patterns, but instead 
were able to adhere to both the collagen patterns as well as the untreated area of the 
silicone well plate. While some cells did adhere to the collagen only, the ability of the 
cells to attach to the well plate allowed significant cross over among the patterned lines. 
In Figure 4.6A, control VSMCs did not form into a specific pattern. The Pluronic 
solutions were not able to effectively eliminate non-specific binding of VSMCs on 
micropatterned surfaces (as described in Chapter 3.4.5). Overall, microstamping collagen 
onto the silicone well plates did not promote significant cell adhesion in the desired 
patterns. To combat this issue in future experiments, stencil patterning was performed to 
produce better alignment of VSMCs for stretching.  
 Figure 4.6B shows VSMCs after they received the stretching regimen. The cells 
demonstrated a more elongated phenotype while adhering to collagen in a line resembling 
the original collagen pattern. This finding supports literature that states vascular smooth 
muscle cells exhibit a more contractile phenotype when stretched. The transition to a 
contractile phenotype could be due to the presence of extracellular matrix cues from the 
micropatterned collagen in combination with the mechanical forces applied to the cells.    
A. B. 
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4.4.3 Stretching Stencil Patterned VSMCs (Trial 1) – Methods    
 To determine the effect of cyclic stretching on cell phenotype and proliferation 
rate, VSMCs were plated in line patterns using PDMS stencils. The MechanoCulture FX 
Mechanical Stimulation System, Version 1, by CellScale was used as the cell stretching 
system. 
 
 
Figure 4.7: Overview of methods of stenciling and stretching VSMCs (Trial 1) 
 First, specialized silicone well-plates were sterilized with 100% ethanol for 1 hour 
and UV light for 45 minutes. The ethanol was removed, and the plates were allowed to 
dry. The experimental plate was secured in the well plate holder of the sterilized cell 
stretching system. A thin layer of collagen (Discovery Labware Inc., Corning) was added 
to each well at a concentration of 100 μL/mL and allowed to incubate overnight to 
provide a better surface for cell adhesion. After 24 hours, collagen was removed from the 
well plates and allowed to dry. PDMS stencils were sterilized by sonicating for 15 
minutes in 100% ethanol. Dried stencils were placed in well-plates in either a parallel or 
perpendicular direction (following the methods described in Chapter 3.4.7). VSMCs 
were passaged using 0.25% Trypsin (Mediatech, Corning) and plated at a density of 
50,000 cells per well. VSMCs were removed after 10 minutes to improve cell adhesion. 
After 24 hours, the stencils were removed from the well-plates, and media was replaced 
in each well. The five experimental groups of cells were: control without a stencil, 
Sterilize Well-plates Collagen Layer Stencil VSMCs Stretch 
Stain + Proliferation Assay Data Analysis 
  66 
control with a stencil, stretched without a stencil, stretched with a parallel stencil, and 
stretched with a perpendicular stencil.  
 The MechanoCulture FX control box was programmed with a set of pre-
conditioning steps along with a stretch representative of normal blood vessel physiology 
for a duration of 24 hours (Table 4.2). Complete programming screen display of the 
MechanoCulture FX software is available in Appendix M. The control box was 
programmed, plugged into a power source, and connected to the well plate holder of the 
cell stretching system in the incubator. To begin cell stretching, the button on the control 
box was pressed once. After the stretching sequence was completed, either a proliferation 
assay was performed or the VSMCs were fixed for immunocytochemistry staining. 
 To begin the proliferation assay, proliferation assay solution (CellTiter 96, 
Promega) was added to the wells in a 1:5 ratio with media. CellTiter 96 is a colorimetric 
proliferation assay that quantifies formazan produced by cells in response to the assay 
solution in order to determine the number of viable cells present
11
. Well plates were 
incubated for 1 hour, and the combined assay/ media solution was transferred to a 96-
well plate. Absorbance values were measured using a Synergy 4 Microplate Reader 
(BioTek) with Gen 5 1.11 Microplate Data Collection & Analysis Software. A two-tailed 
student’s t-test with unequal variance was performed to determine if there is a statistically 
significant difference between the proliferation rates of each sample group.  
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Table 4.2: Program sequence for stretching VSMCs plated in lines using PDMS 
stencils  
Step of Program 
Sequence  
Strain 
(%) 
Stretch 
Displacement 
(mm) 
Frequency 
(Hz)  
Stretch/Recovery 
Duration (s) 
Total Step 
Duration 
(s) 
Initial Stretch - 1.5 - 10.0/ 0.0 10  
Pre-Conditioning 1 0.1333 0.1 5.0/ 5.0  900  
Pre-Conditioning 1 0.1333 0.5 1.0/ 1.0 900  
Pre-Conditioning 1 0.1333 1 0.5/ 0.5 900  
Pre-Conditioning 2.5 0.3333 1 0.5/ 0.5  900 
Heart Physiology  5 0.6666 1 0.5 /0.5 86,400 
 
 Cells were fixed using a 4% formaldehyde (Sigma), 0.1% glutaraldehyde 
(Polysciences, Inc.) solution at room temperature for 20 minutes. Cells were 
permeabilized with a 0.1% Triton X-100 (Sigma) solution at room temperature for 15 
minutes. Cells were blocked with a 2% BSA (Rockland), 3% goat serum (MP 
Biomedicals, LLC) blocking solution. Finally, monoclonal mouse anti-collagen Type 1 
primary antibody (Sigma) in the blocking solution at a concentration of 1:500 was added 
to the wells and allowed to incubate at 4°C overnight. Goat anti-mouse Alexa Fluor 488 
was used as the secondary antibody at a concentration of 4 μL/mL, and it was incubated 
at room temperature for 2 hours. Alexa Fluor 568 Phalloidin (Thermo Fisher Scientific) 
was added at a concentration of 2.5% in PBS for 20 minutes at room temperature to stain 
for the actin cytoskeleton of the cell. 300 nM DAPI (Thermo Fisher Scientific) was added 
for 5 minutes at room temperature to stain for cell nuclei. Cells were rinsed three times 
with 1X PBS (Alfa Aesar) between every solution change. 1X PBS was added to the 
stained wells for storage. Images were taken using the EVOS microscope. Images were 
taken at 4X and 10X, and phenotypes were qualitatively compared among groups.  
Additionally, 4 images were taken of the DAPI-stained nuclei at representative areas of 
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each well, and the number of nuclei for each image were counted. Images of control 
wells were selected randomly, and images of the stretched and patterned wells were 
selected in the patterned regions only (Appendix P).  
4.4.4 Stretching Stencil Patterned VSMCs (Trial 1) – Results and Discussion   
 Proliferation assay data, demonstrated as the comparison of the number of viable 
cells, is shown in Figures 4.8- 4.11 and Tables 4.3- 4.4. Viable cell number is represented 
as an absorbance value as received by the well plate reader. Proliferation rate data is 
supplemented with analysis of the number of nuclei, which is shown in Figure 4.12 and 
Table 4.5. Immunocytochemistry staining images are shown in Figures 4.13- 4.16.  
 
Figure 4.8: Viable cell number of control and stretched VSMCs plated without a stencil, p-value 
(2.03 E-16) indicates that there is a statistically significant difference 
 
 
Viable Cell Number of VSMCs without a Stencil 
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Figure 4.9: Viable cell number of control and parallel or perpendicularly stretched VSMCs plated in 
a line pattern with a stencil 
 
 
Table 4.3: T-Tests comparing the viable cell numbers of stenciled VSMCs; p-values 
indicate that there is a statistically significant difference between all sample groups  
T-Tests for Stenciled 
VSMCs 
Control (No 
Stretch) 
Parallel 
Stretch 
Perpendicular 
Stretch 
Control (No Stretch)       
Parallel Stretch 2.05 E-13     
Perpendicular Stretch  1.60 E-13 1.08 E-2   
 
 
 
 
Figure 4.10: Viable cell number of control VSMCs with and without a stencil, p-value (0.044) 
indicates that there is a statistically significant difference 
 
 
Viable Cell Number of Stenciled VSMCs  
Viable Cell Number of Control VSMCs  
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Figure 4.11: Viable cell number of stretched VSMCs, either non-directional without a stencil or those 
plated with a stencil in parallel or perpendicular directions  
 
 
Table 4.4: T-Tests comparing the viable cell numbers of stretched VSMCs; p-values 
indicate that there is a statistically significant difference between all sample groups  
T-Tests for Stretched 
VSMCs 
No Stencil 
(Non-
Directional) 
Parallel 
Stretch 
Perpendicular 
Stretch 
No Stencil (Non-
directional Stretch)       
Parallel Stretch 0.001     
Perpendicular Stretch 0.029 0.011   
 
 Based on absorbance values from the proliferation assay, the number of viable 
cells of control VSMCs is higher than that of the stretched VSMCs, for both samples 
plated without stencils (Figure 4.8) and those with stencils (Figure 4.9). This data 
supports literature that states stretched VSMCs become more contractile, as seen by the 
lower viable cell number. Figure 4.8 shows that stretched VSMCs have significantly 
lower viable cell numbers than their control counterparts, which is characteristic of 
contractile VSMC functions. As seen in Figure 4.9, both parallel and perpendicularly 
stretched stencil-patterned VSMCs have a lower viable cell number than control stencil-
Viable Cell Number of Stretched VSMCs  
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patterned VSMCs. Table 4.3 confirms that there is a statistically significant difference 
between control and stretched pattern-stenciled VSMCs, as well as between the parallel 
and perpendicularly stretched, stencil-patterned VSMCs.  The viable cell number of 
VSMCs stenciled parallel to the stretch direction was slightly higher than that of the 
perpendicularly stenciled VSMCs. This could be due to a decreased ability to proliferate 
when the cytoskeleton of the cell was arranged perpendicular to stretch.  
 Figures 4.10 and 4.11 demonstrate the effect of stencil patterning on VSMC 
viable cell number. It is expected that the wells without stencils will have a higher 
absorbance value, and thus cell number, due to the greater available surface area for cell 
adhesion. Figure 4.10 shows that the viable cell number of stencil-patterned VSMCs is 
statistically significantly lower than that of non-stenciled VSMCs. This is expected due to 
the decreased surface area caused by the stencil placement in the well. Figure 4.11 
demonstrates a different trend with stretched VSMCs: the stenciled VSMCs actually had 
higher viable cell numbers than the non-stenciled VSMCs. This could be due to an 
inconsistency in stencil size, shape, and well placement. Conflicting trends could also be 
due to the high seeding density of cells, so this was adjusted in the next experiment. 
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Figure 4.12: Number of Nuclei in VSMCs (Trial 1) 
 
Table 4.5: T-Tests comparing number of nuclei between control, stretched, stencil-
patterned, and non-stenciled VSMCs  
T-Tests 
Control- No 
Stencil 
Control- 
Stencil 
Stretch- No 
Stencil 
Stretch- 
Parallel 
Stretch- 
Perpendicular 
Control- No Stencil           
Control- Stencil 0.532         
Stretch- No Stencil 0.241 0.637       
Stretch- Parallel 0.139 0.322 0.343     
Stretch- Perpendicular 0.294 0.624 0.842 0.613   
 
 The number of nuclei represents the cell density of VSMCs in a particular region 
of the pattern. There is not a statistically significant difference between any of the 
experimental groups, which is likely due to the high variability present in each group 
(Table 4.5). The variability of nuclei number could be due to the inconsistency of cell 
spreading throughout the wells. However, some trends are seen that support the 
proliferation assay data. Both control groups have a larger number of nuclei than 
stretched cells.  
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Figure 4.13: Control, non-stretched VSMCs, A. No stencil, B. Stencil-patterned (4X) 
 
  
Figure 4.14: Control, non-stretched VSMCs, A. No stencil, B. Stencil-patterned (10X) 
 
  
A. 
A. 
A. 
B. 
B. 
B. 
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Figure 4.15: Stretched VSMCs, A. No stencil, B. Parallel stencil, C. Perpendicular stencil (4X)  
 
  
 
Figure 4.16: Stretched VSMCs, A. No stencil, B. Parallel stencil, C. Perpendicular stencil (10X)  
 
 The efficacy of the stencil patterning technique was revealed through staining and 
imaging. Figure 4.13 shows both control and stencil-patterned non-stretched VSMCs. 
While non-patterned VSMCs exhibit random arrangement and cell spreading (Figure 
4.13A), the stencil-patterned VSMCs are more aligned. However, the high seeding 
C. 
A. B. 
C. 
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density along with an allotted 24 hours to migrate and proliferate after the stencil was 
removed allowed for a high amount of cell spreading between the two patterned lines 
seen in Figure 4.13B. Figure 4.14 supports this trend, with cell spreading from the 
original stencil outline visible in Figure 4.14B. Successful cell stenciling with minimal 
spreading was also demonstrated with stretched VSMCs (Figures 4.15- 4.16). Cell 
spreading could be reduced by using a more precisely fabricated stencil with sharper 
edges and corners that will adhere to the well plate. 
 Stretched VSMCs exhibit significant phenotype changes compared to control 
cells. As seen in Figure 4.15 and 4.16, stretched VSMCs appear to be more round and 
less adhered to the well plate surface. There are several hypotheses for the cause behind 
this phenotype. First, it is possible that the initial pre-stretching step of 1.5 mm (Table 
4.2) caused too much displacement of the well plate, disrupting cell adhesion. The 
subsequent stretching regimen then might have prevented the cells from forming strong 
new attachments to the well plate after the initial disruption, leading to the small, rounded 
phenotype displayed.  Another hypothesis is that the specialized well plate was placed in 
tension in its position in the well plate holder of the cell stretching system. When it was 
removed from the well plate holder for staining, the tension in the well plate was 
released, perhaps disrupting the cell attachment to the surface. Additionally, the collagen 
layer on the well plate could affect cell interactions and mechanics, leading to the cells 
not fully adhering to the surface.  
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4.4.5 Stretching Stencil Patterned VSMCs (Trial 2) – Methods    
 To determine the effect of cyclic stretching without the initial pre-conditioning 
stretch step, VSMCs were plated in line patterns using PDMS stencils. The 
MechanoCulture FX Mechanical Stimulation System, Version 1, by CellScale was used 
as the cell stretching system. 
  
 
Figure 4.17: Overview of methods of stenciling and stretching VSMCs (Trial 2) 
 
 The same methods described for Trial One (as described in Chapter 4.4.3) were 
followed for Trial Two, with a few changes as specified. VSMCs were plated at a density 
of 10,000 cells per well and were not removed following plating. Due to well plate 
limitations, VSMCs were only stencil-patterned. However, a Day 0 control group was 
added to analyze phenotypic and proliferation changes over time. The four experimental 
groups of cells were: Day 0 control, Day 1 control, parallel stretched (Day 1), and 
perpendicularly stretched (Day 1). The cell stretching program sequence was adjusted to 
remove any initial stretching, as seen in Table 4.6. Finally, a proliferation assay and 
immunocytochemistry staining were performed.  
Table 4.6: Program sequence for stretching VSMCs plated in lines using PDMS 
stencils  
Step of Program 
Sequence  
Strain 
(%) 
Stretch 
Displacement 
(mm) 
Frequency 
(Hz)  
Stretch/Recovery 
Duration (s) 
Total Step 
Duration 
(s) 
Pre-Conditioning 1 0.1333 0.1 5.0/ 5.0  900  
Pre-Conditioning 1 0.1333 0.5 1.0/ 1.0 900  
Pre-Conditioning 1 0.1333 1 0.5/ 0.5 900  
Pre-Conditioning 2.5 0.3333 1 0.5/ 0.5  900 
Heart Physiology  5 0.6666 1 0.5 /0.5 86,400 
Sterilize Well-plates Collagen Layer Stencil VSMCs Stretch 
Stain + Proliferation Assay Data Analysis 
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4.4.6 Stretching Stencil Patterned VSMCs (Trial 2) – Results and Discussion   
 Proliferation assay data, demonstrated as the comparison of the number of viable 
cells, is shown in Figures 4.18- 4.19 and Table 4.8. Viable cell number is represented as 
an absorbance value as received by the well plate reader. Proliferation rate data is 
supplemented with analysis of the number of nuclei, which is shown in Figure 4.20 and 
Table 4.9. Immunocytochemistry staining images are shown in Figures 4.21- 4.23.  
 
Figure 4.18: Viable cell number of control and stretched (combined parallel and perpendicular) 
VSMCs 
 
Table 4.7: T-Tests comparing the viable cell numbers of control and stretched 
VSMCs; p-values indicate that there is a statistically significant difference between 
all sample groups  
T-Tests 
Day 0 
Control 
Day 1 
Control 
Stretch 
Day 0 Control       
Day 1 Control 1.104 E-4      
Stretch  1.893 E-9  2.602 E-13    
 
Viable Cell Number of VSMCs after Stretch 
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Figure 4.19: Viable cell number of parallel and perpendicular stretched cells, p-value (0.493) 
indicates that there is not a statistically significant difference 
  
 Results from Trial 2 mirrored that of Trial 1: the viable cell number of stretched 
VSMCs were lower than that of the control counterparts (Figure 4.18). Decreased viable 
cell number, representative of proliferation rate, are characteristic of a contractile 
phenotype. Additionally, it was seen that viable cell number of control VSMCs decreased 
from Day 0 to Day 1. This suggests that the well plate environment might not have been 
sufficient for prolonged cell growth. In the future, VSMCs can be seeded at a lower 
density, or different extracellular matrix proteins, such as fibronectin, could be used as a 
surface layer to promote increased cell proliferation. Figure 4.19 indicates that there is 
not a statistically significant difference between parallel and perpendicularly stretched 
cells.  
Viable Cell Number of Stretched VSMCs  
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Figure 4.20: Number of Nuclei in VSMCs (Trial 2) 
 
Table 4.8: T-Tests comparing number of nuclei between Day 0 control, Day 1 
control, parallel and perpendicularly stretched VSMCs   
T-Tests 
Day 0 
Control 
Day 1 
Control 
Parallel Perpendicular 
Day 0 Control         
Day 1 Control 0.01173       
Parallel 0.00040 0.03834     
Perpendicular  0.00536 0.07861 0.79165   
  
 Analysis of the number of DAPI-stained nuclei in selected representative images 
supports proliferation assay data. The number of nuclei is greater in the control than in 
the stretched VSMCs (Figure 4.20). Further, the number of nuclei is less in the Day 1 
control compared to the Day 0 control, complementing the associated proliferation rates. 
There is not a statistically significant difference between the parallel and perpendicularly 
stretched VSMCs, possibly due to similar mechanical conditions or similar limited 
surface areas (Table 4.8). The large variability in each group could be due to the 
variability of cell spreading.  
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Figure 4.21: Stencil Patterning: Day 0 Control (4X) 
 
  
Figure 4.22: Control VSMCs, A. Day 0 Control, B. Day 1 Control (10X) 
  
Figure 4.23: Stretched VSMCs, A. Parallel stencil, B. Perpendicular stencil (10X) 
 Stencil patterning was shown to be effective at aligning VSMCs into parallel lines 
(Figure 4.21). Day 0 control VSMCs were found to be more confluent than Day 1 control 
VSMCs, suggesting that there was a secondary cause for the decreased proliferation rates 
(Figure 4.22). Further, stretched VSMCs exhibited significant phenotype changes 
A. 
A. 
B. 
B. 
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compared to both day 0 and 1 control cells. The same hypotheses suggested for Trial 1 
apply to this experiment as well.  
 
4.5 CONCLUSIONS AND FUTURE DIRECTION  
 Overall, stencil patterning was the most effective way to align VSMCs on the 
silicone well plates for cell stretching experiments. Stencil patterned VSMCs exhibited a 
much more aligned arrangement with reduced cell spreading and random attachment 
compared to VSMCs plated on micropatterned collagen. Improvements to the stencil 
patterning method include creating uniform stencils with a standardized size and shape. 
Laser cutting PDMS stencils would be a better fabrication method that would allow for 
higher quality, better performing stencils. PDMS stencils could also be produced using a 
master with taller photoresist features.  
 While cell stretching promoted a more contractile phenotype when VSMCs were 
plated on microstamped collagen, some additional modifications in the stencil patterning 
experiments led to the display of a rounded, unattached phenotype. Future stretching 
experiments would not include an initial stretching step, and the stretched well plate 
would remain in the well plate holder of the cell stretching system for staining and 
imaging to prevent disruption of the cell attachments to the well plate.  
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Appendix A 
Vascular Smooth Muscle Cell Culture Protocol 
Materials:  
1. Smooth muscle cell growth medium (Cell Applications, Inc., Cat. No. 311-500)  
2. 0.25% Trypsin, 2.21 mM EDTA, 1X sodium bicarbonate (Mediatech, Inc., a Corning 
subsidiary, REF 25-053-CI)  
 
Passaging Cells Procedure:  
1. Remove media from cell culture flask.  
2. Add thawed Trypsin to flask to cover the surface, (5 mL for T-75 flask, 10 mL for T-160 
flask). 
3. Incubate for 5-7 minutes, until cells become detached from the flask surface. 
4. Add equal amount of warmed media to the flask. 
5. Transfer the media/trypsin solution to a 15 mL centrifuge tube. 
6. Centrifuge media/trypsin solution at 1,000 rpm for 5 minutes. 
7. Cell pellet will form at bottom of centrifuge tube. 
8. Remove supernatant from cell pellet. 
9. Add 1 mL of media and vortex to evenly distribute cells throughout the solution. 
10. Plate cells into cell culture flask or well plate.  
 
Thawing Cells Procedure:  
1. Remove cryogenic vial of frozen cells from the liquid nitrogen tank.  
2. Thaw cryogenic vial as quickly as possible, placing in water bath as necessary. 
3. Transfer cell suspension into a 15 mL centrifuge tube with 5 mL of warmed media.  
4. Centrifuge solution at 1,000 rpm for 5 minutes.  
5. Cell pellet will form at bottom of centrifuge tube. 
6. Remove supernatant from cell pellet. 
7. Add 1 mL of media and vortex to evenly distribute cells throughout the solution. 
8. Plate cells into cell culture flask or well plate.  
 
Notes: All cell culture procedures are sterile and performed in a standard laminar flow hood. 
Smooth muscle cell growth medium is light sensitive and is stored as such.   
 
References:  “Protocol for Passaging Adherent Cells”, Gibco Cell Culture Basics, Thermo 
Fisher Scientific. Web. 2018. https://www.thermofisher.com/us/en/home/references/gibco-cell-
culture-basics/cell-culture-protocols/subculturing-adherent-cells.html#4  
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Appendix B 
Counting Cells Protocol  
Materials:  
1. Trypan blue dye solution, 0.4% (Sigma, T8154)  
2. Bright-Line hemocytometer (Hausser Scientific)  
3. Smooth muscle cell growth medium (Cell Applications, Inc., Cat. No. 311-500) 
 
Procedure:  
1. Passage cells, leaving a 1 mL suspension of cells in media. 
2. In a 1 mL centrifuge tube, add 160 μL media, 20 μL of cell suspension, and 20 μL of Trypan 
blue dye solution.  
3. Vortex the combined solution to mix.   
4. Add 20 μL of the combined cell/dye solution to a hemocytometer.  
5. Count the number of cells present in the 5 marked squares in the hemocytometer grid shown in 
Figure B-1:  
 
Figure B-1: Counting cells using a hemocytometer grid  
 
6. Determine the number of cells per mL of original cell suspension with the following equation:  
Total # of Cells/ mL = (COUNT/5) x 10 x (10^4) 
7. Determine the number of cells needed for plating with the following equation:  
Amount of Solution Needed (μL) = (# of Cells Needed/ Total # of Cells/mL) x 1000 
 
References: “Counting cells using a hemocytometer”, Abcam. Web. 2018. 
http://www.abcam.com/protocols/counting-cells-using-a-haemocytometer.  
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Appendix C 
Proliferation Assay Protocol 
 
Materials:  
1. CellTiter 96 AQueous One Solution Cell Proliferation Assay (Promega Corporation, REF 
G3581) 
2. Smooth muscle cell growth medium (Cell Applications, Inc., Cat. No. 311-500) 
 
Procedure:  
Begin Assay Incubation  
1. Remove media from the wells. 
2. Add fresh media to each well. 
3. Add proliferation assay to each well. 
 1:5 Ratio for Assay: Media  
4. Incubate for 1 hour at 37°C.  
 
Read Absorbance Using Well Plate Reader   
1. Remove 120 μL of the combined assay/media solution and transfer to a 96-well plate, 
repeating until well is depleted  
2. Repeat for each well  
3. Read absorbance values using the Synergy 4 Microplate Reader by BioTek  
4. On Gen 5 1.11 Microplate Data Collection & Analysis Software, click the following: 
 Read a Plate  
 Instrument Selection > Synergy 4 > Ok 
 Procedure > Plate Type: 96 WELL PLATE  
 Read > Set “Absorbance” to 490 nm > Ok  
 Description: Read: (A) 490  
 Plate 1 Reading > READ  
 Name and Save the file  
5. After “Place plate on carrier” notification appears, load the well plate onto the tray, remove the 
lid, and click Ok 
6. Tray will automatically close and read the plate  
7. When reading is complete, on “Plate 1” tab, select “490” from the “Data” selection tab to show 
the absorbance readings  
8. Export the data to Excel for analysis  
9. Remove the well plate, close the tray, and turn off the well plate reader  
 
References: “CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay Technical 
Bulletin”, Promega, Promega Corporation. Web. 2018. 
https://www.promega.com/resources/protocols/technical-bulletins/0/celltiter-96-aqueous-
nonradioactive-cell-proliferation-assay-protocol/ 
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Appendix D 
Proliferation Assay Standard Curve Protocol 
 
Materials:  
1. CellTiter 96 AQueous One Solution Cell Proliferation Assay (Promega Corporation, REF 
G3581) 
2. Smooth muscle cell growth medium (Cell Applications, Inc., Cat. No. 311-500) 
 
Procedure: 
Plate Cells 
1. Passage and count cells.  
2. Plate cells in triplicates in a 24- well plate for the following seeding densities (Figure D-1): 
1,000; 2,500; 5,000; 10,000; 25,000; 50,000; 100,000; 200,000  
Note: Higher seeding densities can be added depending on seeding density used in experiments.  
3. Add 1 mL of media per well.  
4. Incubate for 4-6 hours at 37°C.  
 
    
Figure D-1. Well Plate Layout, A. Culturing Cells in 24- Well Plate, B. Proliferation Assay Solution 
in 96- Well Plate  
 
Begin Assay Incubation  
1. Remove media from the wells. 
2. Add fresh media to each well (333.3 uL). 
3. Add proliferation assay to each well (66.7 uL). 
 1:5 Ratio for Assay: Media  
4. Incubate for 1 hour at 37°C.  
 
Read Absorbance Using Well Plate Reader   
Follow steps as described in Appendix C. 
 
 
1,000 
2,500 
10,000 
5,000 
25,000 
50,000 
100,000 
200,000 
A. B. 
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Create Standard Curve in Excel 
1. Find average absorbance for each seeding density  
2. Plot Absorbance vs. Cell Number as a scatterplot, including the trendline 
3. The equation for the trendline is the standard curve equation that can be used to determine an 
approximate cell number based on the absorbance readings: 
CELL NUMBER = m (ABSORBANCE) - b 
 
References: “CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay Technical 
Bulletin”, Promega, Promega Corporation. Web. 2018. 
https://www.promega.com/resources/protocols/technical-bulletins/0/celltiter-96-aqueous-
nonradioactive-cell-proliferation-assay-protocol/ 
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Appendix E 
Immunocytochemistry (ICC) Staining Protocol 
 
Purpose: ICC Staining allows for specific staining of a protein or cellular product using a 
primary antibody to bind to the desired antigen. A fluorescent secondary antibody binds to the 
primary antibody to allow for visualization of the stain using a fluorescent microscope.  
 
Materials:  
1. Phosphate-buffered saline (PBS), 1X (Alfa Aesar, J61196)  
2. 37% Formaldehyde Solution in H2O (Sigma, F8775)  
3. 8% EM Grade Glutaraldehyde (Polysciences, Inc., 07710)  
4. Triton X-100 (Sigma, 234729)  
5. Bovine Serum Albumin (Rockland, BSA-50)  
6. Goat Serum (MP Biomedicals, LLC, 191356)  
7. Alexa Fluor 568 Phalloidin (Invitrogen by Thermo Fisher Scientific, A12380)  
8. DAPI: 4',6-diamidino-2-phenylindole, dihydrochloride (Invitrogen by Thermo Fisher 
Scientific, D21490)  
 
Procedure:  
Day 1 Primary Staining: 
1. Fix cells using a 4% formaldehyde, 0.1% glutaraldehyde solution in 1X PBS for 20 minutes at 
room temperature.  
2. Rinse gently 3 times with 1X PBS. 
3. Permeabilize cells with a 0.1% Triton X-100 solution in 1X PBS for 15 minutes at room 
temperature.  
4. Rinse gently 3 times with 1X PBS.  
5. Block cells using a 2% BSA, 3% goat serum solution in 1X PBS for 30 minutes at room 
temperature.   
6. Add primary antibody diluted in blocking solution, and incubate overnight at 4°C.  
 Primary Antibody: Mouse Anti-Collagen Type 1, monoclonal (Sigma Life Science, 
 REF: C2456) 
 
Day 2 Secondary Staining:  
1. Save primary antibody for future uses. 
2. Rinse gently 3 times with 1X PBS. 
3. Add fluorescent secondary antibody at a concentration of 4 μL/mL in 1X PBS.  
 Secondary Antibody: Alexa Fluor 488 (green) Goat Anti-Mouse IgG H+L (Thermo 
 Fisher Scientific, Cat. #: A-11001)  
4. Rinse gently 3 times with 1X PBS. 
5. Add 2.5% Alexa Fluor 568 Phalloidin (red) in 1X PBS for 20 minutes at room temperature.  
6. Rinse gently 3 times with 1X PBS.  
  90 
7. Add 300 nM DAPI solution (blue) in 1X PBS for 5 minutes at room temperature.  
8. Rinse gently 3 times with 1X PBS and store in PBS to image. 
9. Image with EVOS fluorescent microscope. 
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Appendix F  
Fabrication of Stamp Master Using Photolithography Protocol 
 
Purpose: Photolithography is used to transfer patterns from a high-resolution photomask onto the 
photoresist-covered silicon wafer used as the stamp master.  
 
Materials:  
1. Photoresist: SU-8 2005 (Microchem Corp.)  
2. Substrate: 3’’ Diameter Polished Silicon Wafer (University Wafer)  
3. Isopropyl Alcohol  
4. SU-8 Developer (Microchem Corp.)  
 
Procedure:  
Protocol Preparation:  
Ensure proper Clean Room PPE is worn.  
Turn on nitrogen gas tanks to UV lamp and nitrogen gun.  
 
UV Exposure Calibration (Part One) 
1. Ensure that N2 is connected to both the mask aligner and UV controller, and turn on 
‘nitrogen’ switch to ensure proper arc lamp cooling. 
o Required UV controller pressure = 1.5 bar 
o Required Mask aligner pressure = 2.0 bar 
2. Turn on power for both UV controller and mask aligner. 
3. On the UV controller, press the green button to ignite the UV arc lamp.  
o Allow the arc lamp to warm up for at least 10 min to avoid damaging the lamp. 
After ignition, the display will decrease to ~150 W, and then slowly increase and 
stabilize at ~197 W. 
Substrate (Silicon Wafer) Preparation: 
1. Preheat hot plate (in chemical hood) to 95°C. 
2. Spray silicon wafer with isopropyl alcohol (IPA), and blow dry with nitrogen gas. 
3. Place wafer directly onto the hot plate for 2-5 min, and cover with petri dish to prevent 
dust contamination. 
Photoresist Spin-coating: 
1. In order to prevent contamination by dust/debris, blow silicon wafer with nitrogen gas. 
2. Turn vacuum on, turn blue valve (pressure around 22).  
3. Place wafer on spin-coater chuck (in chemical hood), and apply vacuum. 
4. Add 1 mL SU8-2005 for every inch in diameter of wafer (~2 mL total, enough to cover 
desired area of wafer. Apply an even coat with no bubbles). 
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5. Close the lid of the spin-coater, and spin-coat slide with photoresist using the following 
settings: 
 500 rpm for 10 seconds 
 3000 rpm for 30 seconds 
 500 rpm for 10 seconds 
 Film Thickness: 5 um  
(To do this, Select Program, Change Settings, F1 when done, Run to begin.)  
6. If other film thicknesses are needed, refer to the manufacturer specification sheet to find 
appropriate spin-coating settings.  
Soft Bake: 
1. Place coated wafer on a 95°C hotplate for 2 minutes. 
2. Remove wafer from hotplate, and store in a container protected from light. 
Photomask Preparation: 
1. Cut the photomask to fit on the wafer. 
2. Use tape to secure the border of the photomask to the wafer without covering the 
photomask pattern. 
UV Exposure Calibration (Part Two) 
1. Press the ‘display’ button to change the display units to mW/cm2 
2. Press the ‘channel’ button to change to the desired channel, and press the ‘set’ button to 
display the channel settings: 
o Channel 1: Intensity ~ 2.93 mW/cm
2
, OR 
o Channel 2: Intensity ~ 4 mW/cm
2
 
3. Calculate the desired exposure time: ~31 seconds 
o Time (s) = Dose (mJ/cm
2
) / Intensity (mW/cm
2
) 
o For 5 um thickness, recommended dose = 90-105 mJ/cm
2
 
4. On the mask aligner control panel, turn the dial knob to the desired exposure time, and 
adjust the time units using the center knob. 
UV Exposure  
1. Use nitrogen gas to remove any excess debris from the photomask and glass-backing. 
2. Pull out the metal mask holder from the exposure system, invert the photomask and 
glass-backing, and align with the metal mask holder. 
3. Press the ‘mask vacuum’ button to hold the mask and glass-backing in place. 
4. Slide the mask holder in place, and use the 2 black knobs to secure the mask holder. 
5. Use nitrogen gas to remove any excess debris from the photoresist-coated wafer. 
6. Pull out the substrate holder on the right side of the mask aligner, place photoresist-
coated wafer on the holder, and slide holder back into place. 
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7. Press the ‘separation’ lever backwards on the bottom-left side of the mask aligner, and 
slide the ‘contact’ lever upwards and counterclockwise until the photomask and substrate 
are in contact. 
o When wafer is in contact with the mask, rainbow rings will be seen on mask 
8. Press the ‘vacuum chamber’ button on the mask aligner control panel. 
9. Press the green button on mask aligner control panel in order to open the arc lamp 
shutter. 
o Avoid looking at UV light/reflection during exposure. 
10. After exposure, turn the ‘contact’ knob completely clockwise to release the photomask 
and substrate. 
Post-Exposure Bake (PEB): 
1. Immediately place wafer on a 95°C hotplate for 3 minutes. 
2. Remove wafer from the hotplate and allow to cool to room temperature while protected 
from light.  
 
Photoresist Development: 
1. In a fume hood, rinse exposed wafer with SU-8 developer in all directions for 
approximately 1 minute. 
o Hold slide with tweezers, and avoid contact with developer.  
2. Rinse wafer with isopropyl alcohol (IPA) 
o While still covered in IPA, inspect the wafer under an upright microscope for the 
presence of undeveloped photoresist. If black particles remain present between 
features, continue to rinse wafer with SU-8 developer until particles are removed. 
3. Carefully dry the developed wafer dry using nitrogen gas. 
4. Inspect the dried wafer under a microscope to ensure the integrity of the features. 
Hard Bake: 
1. Place wafer on a 150°C hotplate for 30 minutes to completely cross-link photoresist. 
2. Dispose of developer/IPA waste in a waste container in back of hood. 
3. Turn off all equipment and nitrogen tanks outside the lab when finished.  
 
References:  
“Karl Suss MJB3 UV400 Mask Aligner Standard Operating Procedure.” Version 1.0. 
Nanotechnology Research Center, University of Texas at Arlington. February, 2014. 
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Appendix G 
Fabrication of PDMS Stamps from Master Wafer Protocol 
Materials: 
1. Octyl (trichlorosilane) (Sigma)  
2. Sylgard 184 Silicone Elastomer Base and Elastomer Curing Agent (Dow Corning, 4019862)  
 
Procedure:  
Master Silanization: 
1. Place master in a vacuum desiccator. 
2. In a fume hood, add 50 uL octyl(trichlorosilane) to a plastic petri dish, and place dish in 
the desiccator. 
3. Place the lid on the desiccator, connect the desiccator to the house vacuum, and turn on 
house vacuum for 20 minutes to evacuate the chamber. 
4. Store master in the sealed desiccator overnight (12-16 hours) to allow vapor deposition to 
occur. 
Note: Masters should be re-silanized approximately every 10 uses. 
 
Poly(dimethylsiloxane) (PDMS) Preparation: 
1. Weigh desired amount of Sylgard 184 base into a weigh boat. 
2. Add Syglard 184 curing agent at a 10:1 ratio (base:curing agent) 
3. Mix the polymer for 10 minutes using a clean glass stir rod. 
Note: Prepared PDMS may be stored at 4°C for 1-2 weeks. 
 
Negative-patterned Stamp Fabrication: 
1. Place master inside a plastic petri dish and add PDMS for the desired stamp thickness.  
2. Place inside a vacuum desiccator. 
3. Place the lid on the desiccator, connect the desiccator to the house vacuum, and turn on 
vacuum for 10 minutes to remove air bubbles from PDMS. 
o After degassing is complete, close the desiccator valve, disconnect house 
vacuum, and slowly allow air back into the desiccator. 
4. Bake for at least 30 minutes to 1 hour on a 70°C hot plate, or until fully hardened. 
5. After baking is complete, allow master to cool to room temperature. 
6. Slowly peel PDMS layer away from master, using a scalpel or forceps as necessary. 
7. Cut stamps from PDMS layer based on the pattern design, and store stamps in ethanol. 
References: “Sylgard® 184 Silicone Elastomer”. Dow Corning, Dow Corning Corporation. 
April 2, 2014.  
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Appendix H 
Microstamping Collagen Protocol 
Materials:  
Collagen Type I, Rat Tail, 4.04 mg/mL (Discovery Labware, Inc., Corning, REF 354236)  
Ultrasonic Cleaner (VWR International, Model 75HT)  
 
Procedure:  
Stamp Preparation:  
1. Sterilize stamps by sonicating in 100% ethanol for 15 minutes. 
2. In laminar hood, rinse stamps 3X with 100% ethanol. 
3. Allow stamps to dry completely. 
 
Stamping:  
1. “Ink” the stamp by adding 100 μL of 100 μg/mL collagen to the patterned side of the stamp for 
1 hour. 
2. Place stamping substrate in UV-ozone chamber for 15 minutes.  
3. Remove the collagen from the stamp and rinse 2X with 1X PBS. 
4. Allow the stamps to air dry completely. 
5. With tweezers, “stamp” by placing the stamps pattern-down onto the stamping substrate for 30 
minutes. 
Note: Press down on the corners of the stamp to ensure the stamp is in contact with the surface, 
but do not press down. 
6. Remove the stamps to reveal the final collagen pattern. 
 
Clean Stamps to Reuse:  
1. Rinse stamps ~10 times with 100% ethanol. 
2. Sonicate in 100% ethanol for 15 minutes. 
3. Store stamps in ethanol with the pattern side facing up. 
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Appendix I 
Stencil Patterning Cells Protocol 
 
Materials:  
Collagen Type I, Rat Tail, 4.04 mg/mL (Discovery Labware, Inc., Corning, REF 354236)  
Ultrasonic Cleaner (VWR International, Model 75HT)  
 
Procedure:  
Substrate and Stencil Preparation: 
1. Coat substrate surface with 100 μg/mL collagen and incubate at 37°C overnight. 
2. Remove collagen and allow to dry completely. 
3. Sterilize stencils by sonicating in 100% ethanol for 15 minutes. 
4. In laminar hood, rinse stencils 3X with 100% ethanol. 
5. Allow stencils to dry completely. 
 
Stencil Patterning:  
1. Place PDMS stencils on collagen-coated substrate surface, pressing firmly to ensure the stencil 
is completely adhered to the surface.  
2. Plate cells and allow to adhere for 24 hours. 
3. Remove the stencils and replace media. 
 
Clean Stencils to Reuse:  
1. Rinse stencils ~10 times with 100% ethanol. 
2. Sonicate in 100% ethanol for 15 minutes. 
3. Store stencils in ethanol. 
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Appendix J 
Cell Stretching Protocol   
Materials:  
1. Well Plate Carrier Assembly (CellScale)  
2. Silicone Well Plate (CellScale) 
3. Programming Control Box (CellScale) 
4. Power Supply, USB Cable, and Box/Stretcher Connection Cable (CellScale) 
 
Procedure:  
Develop Cell Stretching Sequence Using Software: 
1. Install MechanoCulture Software. 
2. After connecting the Control Box to the power supply, connect to the computer using USB 
cable, ensuring the screen displays “Connected”. 
3. Develop a Testing Sequence by clicking “Insert Above” or “Insert Below” to add a test step to 
the program. 
4. Adjust test parameters (control function, stretch magnitude, time units, stretch duration, hold 
duration, recovery duration, rest duration, and repetitions) by double clicking on each step. 
5. Program the Control Box by clicking “Program”. 
6. Verify the test sequence has been correctly programmed by clicking “Read”. 
 
Prepare well plate:  
1. Modify silicone well plate by making cuts as demonstrated by the red lines in Figure J-1 to 
create more uniform axial strains (Tables J-1 and J-2, modified from CellScale user manual). 
2. Sterilize by filling wells with 100% ethanol for 1 hour, followed by 30 minutes of UV light 
exposure. 
 
Figure J-1: Well plate modification indicated by red lines cut next to the wells [CellScale] 
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Table J-1: Percent Axial Strain of Well Pairs for Modified Well Plate 
Well 1a/b 2a/b 3a/b 4a/b 5a/b 6a/b 7a/b 8a/b 9a/b 10a/b 11a/b 12a/b 
%Axial 
Strain 
1.444 1.491 1.490 1.514 1.482 1.402 1.546 1.552 1.584 1.604 1.485 1.374 
 
Table J-2: Percent Axial Strain of Well Pairs for Unmodified Well Plate 
Well 1a/b 2a/b 3a/b 4a/b 5a/b 6a/b 7a/b 8a/b 9a/b 10a/b 11a/b 12a/b 
%Axial 
Strain 
0.971 1.074 1.218 1.535 1.901 2.222 0.713 0.794 1.003 1.370 1.866 2.963 
 
Begin Mechanical Stimulation of Cells:  
1. Load the sterilized well plate into the well plate carrier.  
2. Plate cells and add media, using a standard well plate lid to maintain sterility. 
3. Program the Control Box using the MechanoCulture software.  
4. Place the Well Plate Carrier Assembly with plated cells into the incubator. 
5. Connect the Control Box to the Power Supply, and then to the Well Plate Carrier Assembly 
with the connection cable. 
6. Press the button on the Control Box one time to begin stretching sequence .  
 
References: “MechanoCulture FX Mechanical Stimulation System.” User Manual Version 1.2. 
CellScale Biomaterials Testing. 2016. 
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Appendix K 
Legend of Photomask Stamp Designs  
 
Figure K-1: Legend of Photomask Stamp Designs (corresponds with Figure 3.6) 
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Table K-1: Specifications of Stamp Designs corresponding to Figure K-1 
STAMP # PICTURE DESCRIPTION 
1 
 
Parallel Lines 
10 µm lanes 
300 µm spacing 
2 
 
Parallel Lines 
30 µm lanes 
300 µm spacing 
3 
 
Parallel Lines 
50 µm lanes 
300 µm spacing 
4 
  
Diamonds, 45° 
30 µm lanes 
300 µm spacing 
5 
 
Parallel Lines 
100 µm lanes 
300 µm spacing 
6 
 
Parallel Lines 
300 µm lanes 
300 µm spacing 
7 
  
Diamonds, 90° 
30 µm lanes 
300 µm spacing 
8 
  
Diamonds, 90° 
100 µm lanes 
300 µm spacing 
9 
  
Diamonds, 45° 
100 µm lanes 
300 µm spacing 
10 
  
Diamonds, 60° 
30 µm lanes 
300 µm spacing 
11 
  
Diamonds, 60° 
100 µm lanes 
300 µm spacing 
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Figure K-2: Final proof of photomask from CAD/Art services 
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Appendix L 
Results from Microstamping Trials  
 Microstamping procedures were optimized to develop the best patterns. A variety of 
substrates were used, including PDMS gels, polystyrene petri dishes, and glass petri dishes. 
Extracellular matrix proteins collagen and laminin were both patterned, with collagen 
demonstrating the best patterning ability. PDMS and silicone substrates were most effective at 
producing a complete, accurate protein pattern.  
 
  
Figure L-1: A, B. Microstamping Collagen with a weight on PDMS gel (10X) 
 
  
Figure L-2: A, B. Microstamping Laminin with a weight on PDMS gel (10X) 
 
  
Figure L-3: A, B. Microstamping Collagen on polystyrene petri dish without rinsing or drying 
collagen (10X) 
A. 
A. 
A. 
B. 
B. 
B. 
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Appendix M 
Stretching Programs 
 Figures M-1 to M-3 show the test sequences that were used for the stretching experiments 
described in Chapter 4.4, as displayed on the MechanoCulture software. The specific steps are 
outlined in Tables 4.1, 4.2, and 4.6. Figure M-4 shows the test parameters that can be adjusted, 
including stretch magnitude, the duration of stretch and recovery, the number of repetitions and 
the corresponding time for each step.  
 
 
Figure M-1: Test sequence for stretching VSMCs on microstamped collagen experiment, includes an 
initial 0.5 mm stretch step followed by pre-conditioning and 24 hours of normal heart beat 
physiology (corresponds with Table 4.1) 
 
 
Figure M-2: Test sequence for Trial One of stretching VSMCs in stenciled line patterns, includes an 
initial 1.5 mm stretch step followed by pre-conditioning and 24 hours of normal heart beat 
physiology (corresponds with Table 4.2) 
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Figure M-3: Test sequence for Trial Two of stretching VSMCs in stenciled line patterns, includes no 
initial stretch step, with pre-conditioning steps and 24 hours of normal heart beat physiology 
(corresponds with Table 4.6) 
 
 
 
 
Figure M-4: Example of modifying test parameters on MechanoCulture software 
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Appendix N 
Proliferation Assay Data from Stretching Experiments  
 Tables N-1 to N-4 compare the viable cell numbers of control and stretched VSMCs 
plated with or without a stencil for the Trial One experiment of stretching VSMCs in stenciled 
line patterns. Tables N-5 to N-9 compare the viable cell numbers between wells in each sample 
group to determine the variance among each group. A two-tailed student’s t-test with unequal 
variance was performed to determine if there is a statistically significant difference between the 
wells of each sample group.  
 
Table N-1: Viable cell numbers of control and parallel or perpendicularly stretched 
VSMCs plated in a line pattern with a stencil (corresponds with Figure 4.9) 
Viable Cell Numbers of Stenciled VSMCs  
Sample Group 
Average 
Absorbance 
Standard Deviation 
Control (No Stretch) 0.266 0.023 
Parallel Stretch 0.097 0.002 
Perpendicular Stretch 0.095 0.001 
 
Table N-2: Viable cell numbers of the control and stretched VSMCs without a 
stencil (corresponds with Figure 4.8) 
Viable Cell Numbers of Non-Stenciled VSMCs  
Sample Group 
Average 
Absorbance 
Standard Deviation T-Test 
Control (No Stretch) 0.287 0.005 2.03 E-16 
Stretch (Non-directional) 0.094 0.001   
 
Table N-3: Viable cell numbers of non-directional, parallel, and perpendicularly 
stretched VSMCs (corresponds with Figure 4.11) 
Viable Cell Numbers of Stretched VSMCs  
Sample Group 
Average 
Absorbance 
Standard Deviation 
No Stencil (Non-Directional) 0.094 0.001 
Parallel Stretch 0.097 0.002 
Perpendicular Stretch 0.095 0.001 
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Table N-4: Viable cell numbers of control VSMCs plated with or without a stencil 
(corresponds with Figure 4.10) 
 
Table N-5: Viable cell numbers of control samples plated without a stencil; p-value 
(0.297) indicates there is not a statistically significant difference between the wells 
Viable Cell Numbers of Control VSMCs Plated without a Stencil 
Absorbance Values 
Average 
Absorbance 
Standard 
Deviation 
T-Test 
Well 1 0.286 0.282 0.287 0.285 0.003 0.297 
Well 2 0.283 0.291 0.294 0.289 0.006 
 Total Average Absorbance 0.287 0.004 
  
Table N-6: Viable cell numbers of stenciled control samples; p-values are listed for 
Well 1 vs. 2 (4.71 E-4), Well 1 vs. 3 (3.07 E -4), and Well 2 vs. 3 (5.11 E-3), 
respectively, and each indicates a statistically significant difference between the 
compared wells 
Viable Cell Numbers of Control VSMCs Plated with a Stencil 
Absorbance Values 
Average 
Absorbance 
Standard 
Deviation 
T-Tests 
Well 1 0.293 0.290 0.291 0.291 0.002 4.71 E-4 
Well 2 0.264 0.265 0.271 0.267 0.004 3.07 E-4 
Well 3 0.232 0.240 0.247 0.240 0.008 5.11 E-3 
Total Average Absorbance 0.266 0.004 
  
Table N-7: Viable cell numbers of stretched samples plated without a stencil; p-
value (0.116) indicates there is not a statistically significant difference between the 
wells 
Viable Cell Numbers of Stretched VSMCs Plated without a Stencil 
Absorbance Values 
Average 
Absorbance 
Standard 
Deviation 
T-Test 
Well 1 0.094 0.094 0.094 0.094 0.000 0.116 
Well 2 0.093 0.094 0.093 0.093 0.001   
Total Average Absorbance  0.094 0.000   
 
 
 
 
Viable Cell Numbers of Control (No-Stretch) VSMCs  
Sample Group 
Average 
Absorbance 
Standard Deviation T-Test 
No Stencil 0.287 0.005 0.044 
Stencil 0.266 0.023   
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Table N-8: Viable cell numbers of parallel stretch samples; p-values are listed for 
Well 1 vs. 2 (0.205), Well 1 vs. 3 (0.022), and Well 2 vs. 3 (0.016), respectively, and 
indicates a statistically significant difference between Wells 1 and 3, Wells 2 and 3  
Viable Cell Numbers of Parallel Stretched VSMCs  
Absorbance Values 
Average 
Absorbance 
Standard 
Deviation 
T-Tests 
Well 1 0.097 0.094 0.096 0.096 0.002 0.205 
Well 2 0.097 0.097 0.097 0.097 0.000 0.022 
Well 3 0.099 0.099 0.101 0.100 0.001 0.016 
Total Average Absorbance  0.097 0.001   
 
Table N-9: Viable cell numbers of perpendicular stretch samples; p-values are listed 
for Well 1 vs. 2 (0.205), Well 1 vs. 3 (0.158), and Well 2 vs. 3 (0.091), respectively, 
and each indicates there is not a statistically significant difference between the 
compared wells 
Viable Cell Numbers of Perpendicular Stretched VSMCs  
Absorbance Values 
Average 
Absorbance 
Standard 
Deviation 
T-Tests 
Well 1 0.095 0.095 0.095 0.095 0.000 0.205 
Well 2 0.096 0.095 0.098 0.096 0.002 0.158 
Well 3 0.093 0.094 0.095 0.094 0.001 0.091 
Total Average Absorbance  0.095 0.001   
 
 Tables N-10 to N-11 compare the viable cell numbers of control and stretched VSMCs 
for the Trial Two experiment of stretching VSMCs in stenciled line patterns. Tables N-12 to N-16 
compare the viable cell numbers between wells in each sample group to determine the variance 
among each group. A two-tailed student’s t-test with unequal variance was performed to 
determine if there is a statistically significant difference between the wells of each sample group. 
 
Table N-10: Viable cell numbers of control and stretched VSMCs (corresponds with 
Figure 4.18) 
Viable Cell Numbers of Control and Stretched VSMCs 
Sample Group Average Absorbance  Standard Deviation 
Day 0 Control 0.131 0.007 
Day 1 Control 0.114 0.002 
Day 1 Stretch 0.095 0.002 
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Table N-11: Viable cell numbers of stretched VSMCs (corresponds with Figure 
4.19) 
Viable Cell Numbers of Parallel and Perpendicularly Stretched VSMCs  
Sample Group Average Absorbance Standard Deviation T-Test 
Parallel Stretch 0.095 0.001 0.493 
Perpendicular Stretch 0.095 0.002   
 
Table N-12: Viable cell numbers of Day 0 Control samples, p-value (0.001) indicates 
there is a statistically significant difference between the wells 
Viable Cell Numbers of Day 0 Control VSMCs 
Absorbance Values 
Average 
Absorbance 
Standard 
Deviation 
T-Test 
Well 1 0.124 0.126 0.126 0.125 0.001 0.001 
Well 2 0.138 0.135 0.138 0.137 0.002 
 
Total Average Absorbance 0.131 0.007 
 
 
Table N-13: Viable cell numbers of Day 1 Control samples, p-value (0.742) indicates 
there is not a statistically significant difference between the wells 
Viable Cell Numbers of Day 1 Control VSMCs 
Absorbance Values 
Average 
Absorbance 
Standard 
Deviation 
T-Test 
Well 1 0.116 0.116 0.111 0.114 0.003 0.742 
Well 2 0.115 0.112 0.114 0.114 0.002 
 
Total Average Absorbance 0.114 0.002 
 
 
Table N-14: Viable cell numbers of Day 1 Parallel Stretch samples, p-value (0.742) 
indicates there is not a statistically significant difference between the wells 
Viable Cell Numbers of Parallel Stretched VSMCs 
Absorbance Values 
Average 
Absorbance 
Standard 
Deviation 
T-Test 
Well 1 0.095 0.094 0.095 0.095 0.001 0.742 
Well 2 0.094 0.093 0.096 0.094 0.002 
 
Total Average Absorbance 0.095 0.001 
 
 
Table N-15: Viable cell numbers of Day 1 Perpendicular Stretch samples, p-value 
(0.374) indicates there is not a statistically significant difference between the wells 
Viable Cell Numbers of Perpendicular Stretched VSMCs 
Absorbance Values 
Average 
Absorbance 
Standard 
Deviation 
T-Test 
Well 1 0.099 0.094 0.095 0.096 0.003 0.374 
Well 2 0.095 0.093 0.095 0.094 0.001 
 
Total Average Absorbance 0.095 0.002 
 
  109 
 
Table N-16: Viable cell numbers of Day 1 Stretch samples, p-value (0.493) indicates 
there is not a statistically significant difference between the parallel and 
perpendicular samples 
Viable Cell Numbers of Parallel and Perpendicular Stretch VSMCs 
Absorbance Values 
Average 
Absorbance 
Standard 
Deviation 
T-Test 
Parallel Stretch  0.095 0.001 0.493 
Perpendicular Stretch  0.095 0.002    
Total Average Absorbance 0.095 0.002   
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Appendix O 
VSMC Proliferation Assay Standard Curves  
 A standard curve for the proliferation assay was created to approximate viable cell 
number from absorbance readings. The protocol in Appendix D was used to obtain 
average absorbance and cell seeding density values to create a standard curve equation.  
 
Table O-1: Seeding Density and Absorbance Values for Standard Curve #1  
Average 
Absorbance 
Cell Seeding 
Density  
0.11642 1,000 
0.12000 2,500 
0.12758 5,000 
0.15933 10,000 
0.22992 25,000 
0.33017 50,000 
0.47400 100,000 
0.80340 200,000 
 
 
 
Figure O-1: VSMC Standard Curve #1 
 
 
Standard Curve #1 Equation:  
CELL NUMBER = 288,592.75(ABSORBANCE) – 35,976.82  
 
 
 
 
VSMC Proliferation Assay Standard Curve #1 
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Table O-2: Seeding Density and Absorbance Values for Standard Curve #2 
Average 
Absorbance 
Cell Seeding 
Density  
0.11483 0 
0.12217 1,000 
0.13133 2,500 
0.14675 5,000 
0.17817 10,000 
0.24792 25,000 
0.38108 50,000 
0.58708 100,000 
0.84183 200,000 
 
 
 
Figure O-2: VSMC Standard Curve #2 
 
 
 
Standard Curve #2 Equation:  
CELL NUMBER = 260,787.57(ABSORBANCE) – 35,996.68 
 
 
 
 
 
VSMC Proliferation Assay Standard Curve #2 
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Appendix P 
Images of DAPI-Stained VSMCs for Number of Nuclei Analysis 
 
 Table P-1 shows the average number of nuclei for each sample group for the Trial One 
experiment of stretching VSMCs in stenciled line patterns. Figures P-1 to P-5 were used to 
compile the average number of VSMC nuclei for each sample group.  
 
Table P-1: Average Number of Nuclei from DAPI-stained VSMCs at 10X 
(corresponds with Figure 4.12) 
Sample Group 
Count 
1 
Count 
2 
Count 
3  
Count 
4 
Average 
Count 
Standard 
Deviation 
Control- No Stencil 320 542 232 198 323.000 154.786 
Control- Stencil 187 399 333 100 254.750 135.976 
Stretch- No Stencil 175 216 241 248 220.000 32.995 
Stretch- Parallel 284 168 176 9 159.250 113.277 
Stretch- Perpendicular 97 165 399 162 205.750 132.598 
 
 
  
  
Figure P-1: A-D, Control VSMCs plated without a stencil, stained for DAPI (10X) 
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Figure P-2: A-D, Control VSMCs plated with a stencil, stained for DAPI (10X) 
 
 
 
  
  
Figure P-3: A-D, Stretched VSMCs plated without a stencil, stained for DAPI (10X) 
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Figure P-4: A-D, Parallel-Stretched VSMCs plated with a stencil, stained for DAPI (10X) 
 
 
  
  
Figure P-5: A-D, Perpendicularly-Stretched VSMCs plated with a stencil, stained for DAPI (10X) 
 
 Table P-2 shows the average number of nuclei for each well of each sample group for the 
Trial One experiment of stretching VSMCs in stenciled line patterns. Figures P-6 to P-12 were 
used to compile the average number of VSMC nuclei for each sample group.  
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Table P-2: Average Number of Nuclei from DAPI-stained VSMCs at 10X 
(corresponds with Figure 4.20) 
Sample Group 
Well 1 Well 2 
Average 
Count 
Standard 
Deviation  Count 
1 
Count 
2 
Count 
3  
Count 
4 
Count 
5 
Count 
6 
Day 0 Control 75 84 84 61 67 128 83.167 23.794 
Day 1 Control 14 53 55 57 42 58 46.500 16.932 
Parallel  46 22 24 18 35 10 25.833 12.813 
Perpendicular  38 13 19 0 0 0 11.667 15.214 
 
   
Figure P-6: A-C, Well 1 of Day 0 Control VSMCs, stained for DAPI (10X) 
 
   
Figure P-7: A-C, Well 2 of Day 0 Control VSMCs, stained for DAPI (10X) 
 
   
Figure P-8: A-C, Well 1 of Day 1 Control VSMCs, stained for DAPI (10X) 
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Figure P-9: A-C, Well 2 of Day 1 Control VSMCs, stained for DAPI (10X) 
 
   
Figure P-10: A-C, Well 1 of Parallel-Stretched VSMCs, stained for DAPI (10X) 
 
   
Figure P-11: A-C, Well 2 of Parallel-Stretched VSMCs, stained for DAPI (10X) 
 
   
Figure P-12: A-C, Well 1 of Perpendicularly-Stretched VSMCs, stained for DAPI (10X) 
 
Note: No pictures are available for Well 2 of Perpendicularly-Stretched VSMCs because 
no cells were visibly stained in the well.  
 
 
